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Abstract	  
The	  mechanical	  index	  (MI)	  has	  been	  used	  by	  the	  US	  Food	  and	  Drug	  Administration	  (FDA)	  since	  1992	  for	  
regulatory	  decisions	  regarding	  the	  acoustic	  output	  of	  diagnostic	  ultrasound	  equipment.	  Its	  formula	  is	  
based	  on	  predictions	  of	  acoustic	  cavitation	  under	  specific	  conditions.	  Since	  its	  implementation	  over	  2	  
decades	  ago,	  new	  imaging	  modes	  have	  been	  developed	  that	  employ	  unique	  beam	  sequences	  exploiting	  
higher-­‐order	  acoustic	  phenomena,	  and,	  concurrently,	  studies	  of	  the	  bioeffects	  of	  ultrasound	  under	  a	  
range	  of	  imaging	  scenarios	  have	  been	  conducted.	  In	  2012,	  the	  American	  Institute	  of	  Ultrasound	  in	  
Medicine	  Technical	  Standards	  Committee	  convened	  a	  working	  group	  of	  its	  Output	  Standards	  
Subcommittee	  to	  examine	  and	  report	  on	  the	  potential	  risks	  and	  benefits	  of	  the	  use	  of	  conditionally	  
increased	  acoustic	  pressures	  (CIP)	  under	  specific	  diagnostic	  imaging	  scenarios.	  The	  term	  “conditionally”	  
is	  included	  to	  indicate	  that	  CIP	  would	  be	  considered	  on	  a	  per-­‐patient	  basis	  for	  the	  duration	  required	  to	  
obtain	  the	  necessary	  diagnostic	  information.	  This	  document	  is	  a	  result	  of	  that	  effort.	  In	  summary,	  a	  
fundamental	  assumption	  in	  the	  MI	  calculation	  is	  the	  presence	  of	  a	  preexisting	  gas	  body.	  For	  tissues	  not	  
known	  to	  contain	  preexisting	  gas	  bodies,	  based	  on	  theoretical	  predications	  and	  experimentally	  reported	  
cavitation	  thresholds,	  we	  find	  this	  assumption	  to	  be	  invalid.	  	  We	  thus	  conclude	  that	  exceeding	  the	  
recommended	  maximum	  MI	  level	  given	  in	  the	  FDA	  guidance	  could	  be	  warranted	  without	  concern	  for	  
increased	  risk	  of	  cavitation	  in	  these	  tissues.	  However,	  there	  is	  limited	  literature	  assessing	  the	  potential	  
clinical	  benefit	  of	  exceeding	  the	  MI	  guidelines	  in	  these	  tissues.	  The	  report	  proposes	  a	  3-­‐tiered	  approach	  
for	  CIP	  that	  follows	  the	  model	  for	  employing	  elevated	  output	  in	  magnetic	  resonance	  imaging	  and	  
concludes	  with	  summary	  recommendations	  to	  facilitate	  Institutional	  Review	  Board	  (IRB)-­‐monitored	  
clinical	  studies	  investigating	  CIP	  in	  specific	  tissues.	  
1 Introduction	  
The	  acoustic	  output	  levels	  used	  in	  diagnostic	  ultrasonic	  imaging	  in	  the	  United	  States	  have	  been	  subject	  
to	  a	  de	  facto	  limitation	  by	  guidelines	  established	  by	  the	  US	  Food	  and	  Drug	  Administration	  (FDA)	  in	  
response	  to	  the	  Medical	  Device	  Amendments	  of	  1976.	  These	  original	  guidelines	  were	  determined	  based	  
on	  existing	  output	  levels	  at	  that	  time,	  for	  which	  no	  known	  bioeffects	  had	  been	  reported	  (ie,	  preexisting	  
levels).	  As	  such,	  they	  were	  not,	  and	  indeed	  could	  not	  have	  been,	  based	  on	  scientific	  evidence	  related	  to	  
the	  induction	  of	  specific	  bioeffects	  by	  diagnostic	  ultrasound.1	  In	  1992,	  in	  response	  to	  the	  suggestion	  that	  
image	  quality	  could	  be	  enhanced	  for	  some	  applications	  if	  higher	  acoustic	  outputs	  were	  allowed,	  new	  
metrics	  were	  	  developed	  and	  implemented:	  the	  mechanical	  index	  (MI)	  and	  the	  thermal	  index	  (TI).2	  These	  
metrics	  were	  derived	  through	  an	  effort	  to	  relate	  output	  guidelines	  to	  potential	  bioeffects,	  with	  the	  MI	  
addressing	  the	  potential	  risks	  of	  nonthermal	  mechanical	  effects	  during	  diagnostic	  ultrasound	  exams,	  
such	  as	  inertial	  cavitation,	  ie,	  bubble	  motion	  characterized	  by	  a	  large	  expansion	  followed	  by	  a	  rapid,	  
violent	  collapse.	  While	  under	  development,	  there	  was	  debate	  as	  to	  whether	  maximum	  upper	  levels	  
should	  be	  specified	  or,	  alternatively,	  whether	  output	  should	  be	  determined	  via	  risk-­‐benefit	  analysis	  on	  a	  
case-­‐by-­‐case	  basis3	  through	  the	  ALARA	  (as	  low	  as	  reasonably	  achievable)	  principle.4	  Experts	  in	  the	  
ultrasonic	  imaging	  and	  bioeffects	  communities	  were	  on	  both	  sides	  of	  this	  issue.	  The	  1992	  track	  3	  FDA	  
guidelines	  represent	  a	  compromise	  in	  that	  they	  relaxed	  the	  maximum	  recommended	  output	  levels	  for	  
some	  applications	  but	  still	  linked	  overall	  thresholds	  to	  the	  preexisting	  levels	  from	  1976	  through	  the	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derating	  process	  described	  below.5	  Acoustic	  output	  levels	  have	  subsequently	  increased	  within	  the	  
context	  of	  the	  newer	  guidelines.6	  Concurrently,	  new	  imaging	  technologies	  have	  been	  developed	  that	  
employ	  unique	  beam	  sequences	  (ie,	  harmonic	  imaging7	  and	  acoustic	  radiation	  force	  impulse–based	  
elasticity	  imaging	  methods8)	  or	  require	  the	  injection	  of	  stabilized	  microbubbles	  as	  ultrasound	  contrast	  
agents.	  None	  of	  these	  new	  modalities	  were	  well	  developed	  when	  the	  current	  regulatory	  scheme	  was	  
implemented,	  so	  neither	  the	  MI	  nor	  the	  TI	  takes	  them	  into	  account	  in	  an	  optimal	  manner.	  	  In	  2008,	  the	  
American	  Institute	  of	  Ultrasound	  in	  Medicine	  (AIUM)	  issued	  a	  consensus	  report	  on	  potential	  bioeffects	  
of	  diagnostic	  ultrasound.1	  This	  report	  recommended	  that	  the	  AIUM	  take	  the	  lead	  to	  encourage	  the	  FDA	  
to	  develop	  an	  open,	  scientifically	  valid	  process	  for	  assessing	  the	  benefits	  and	  risks	  of	  relaxing	  the	  current	  
regulatory	  guidelines	  for	  specified	  imaging	  conditions.	  In	  2011,	  the	  AIUM	  Output	  Standards	  
Subcommittee	  issued	  a	  report	  reviewing	  the	  TI.9	  In	  2012,	  the	  AIUM	  Technical	  Standards	  Committee	  
convened	  a	  working	  group	  of	  its	  Output	  Standards	  Subcommittee	  to	  examine	  and	  report	  on	  the	  
potential	  risks	  and	  benefits	  of	  conditionally	  increasing	  acoustic	  pressure	  levels	  for	  specific	  clinical	  
imaging	  scenarios	  where	  there	  is	  strong	  expectation	  of	  a	  relatively	  high	  benefit-­‐to-­‐risk	  ratio.	  This	  report	  
is	  the	  result	  of	  that	  effort.	  Production	  of	  a	  companion	  paper	  exploring	  the	  evidence	  for	  potentially	  
reducing	  the	  MI	  under	  certain	  conditions,	  eg,	  when	  using	  ultrasound	  contrast	  agents	  or	  imaging	  lung,	  is	  
in	  its	  initial	  stages.	  	  
In	  the	  following	  sections,	  we	  review	  the	  history	  of,	  and	  the	  scientific	  basis	  for,	  the	  MI,	  define	  an	  acoustic	  
output	  regime,	  and	  specify	  clinical	  applications	  under	  consideration	  for	  conditionally	  increased	  
pressures	  (CIP),	  review	  the	  potential	  risks	  of	  CIP	  in	  this	  regime	  based	  on	  existing	  scientific	  evidence,	  and	  
summarize	  the	  evidence	  for	  the	  potential	  clinical	  benefits	  of	  CIP.	  Finally,	  we	  provide	  summary	  
recommendations.	  
2 The	  Mechanical	  Index	  	  
2.1 US	  FDA	  Acoustic	  Output	  Guidelines	  
US	  FDA	  regulations	  designate	  most	  diagnostic	  ultrasound	  imaging	  and	  Doppler	  devices	  as	  Class	  2,	  which	  
means	  that	  before	  a	  new	  device	  can	  be	  legally	  marketed	  in	  the	  United	  States,	  a	  "510(k)"	  (named	  for	  a	  
section	  of	  the	  1976	  FDA	  Medical	  Device	  Amendments)	  premarket	  notification	  must	  be	  cleared	  by	  the	  
FDA.	  In	  this	  notification,	  a	  device	  sponsor	  or	  applicant	  must	  demonstrate	  that	  the	  device	  is	  substantially	  
equivalent	  in	  terms	  of	  safety	  and	  effectiveness	  to	  either	  a	  device	  legally	  marketed	  before	  May	  28,	  1976,	  
the	  date	  of	  enactment	  of	  the	  FDA	  Medical	  Device	  Amendments,	  or	  to	  a	  device	  that	  has	  been	  legally	  
marketed	  as	  a	  Class	  2	  device	  since	  that	  date.	  To	  evaluate	  equivalent	  safety,	  the	  FDA	  uses	  acoustic	  
output	  quantities,	  including	  the	  MI,	  to	  compare	  maximum	  output	  levels.	  The	  definition	  for	  the	  MI	  used	  
by	  the	  FDA	  can	  be	  found	  in	  IEC	  6235910:	  
	   ( ) 2/1awfMI3.0, −= fzpMI r 	  ,	   (1)	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where	  pr,0.3(zMI)	  is	  the	  attenuated	  (ie,	  derated)	  peak-­‐rarefactional	  acoustic	  pressure	  at	  the	  depth	  zMI	  
(assuming	  an	  attenuation	  coefficient	  [α]	  of	  0.3	  dB	  cm–1	  MHz–1);	  zMI	  is	  depth	  on	  the	  beam	  axis	  from	  the	  
transducer	  to	  the	  plane	  of	  maximum	  attenuated	  pulse-­‐intensity	  integral	  (pii0.3);	  and	  fawf	  is	  the	  acoustic-­‐
working	  frequency.	  
In	  a	  survey	  conducted	  by	  the	  FDA	  and	  others	  of	  diagnostic	  ultrasound	  devices	  on	  the	  market	  prior	  to	  
May	  28,	  1976,	  the	  highest	  MI	  was	  found	  to	  be	  1.9,	  which	  was	  based	  on	  a	  system	  with	  an	  fawf	  =	  2	  MHz.11	  
The	  FDA	  uses	  this	  value	  in	  its	  regulatory	  decisions	  for	  all	  applications	  except	  ophthalmic,	  in	  which	  case	  
an	  MI	  of	  0.23	  (the	  highest	  value	  found	  for	  an	  ophthalmic	  diagnostic	  ultrasound	  device	  prior	  to	  May	  28,	  
1976)	  is	  used.	  	  	  
2.2 Scientific	  Rationale	  for	  MI	  
The	  MI	  was	  developed	  in	  the	  late	  1980s	  from	  theoretical	  calculations	  and	  experimental	  observations.	  	  In	  
their	  theoretical	  development,	  Apfel	  and	  Holland12	  determined	  the	  approximate	  acoustic	  pressure	  
amplitude	  required	  to	  cause	  an	  optimally	  sized	  bubble	  (ie,	  the	  bubble	  size	  having	  the	  lowest	  threshold)	  
to	  undergo	  inertial	  cavitation,	  ie,	  a	  large	  expansion	  followed	  by	  a	  rapid,	  violent	  collapse.	  Such	  a	  collapse	  
can	  radiate	  shock	  waves	  and	  cause	  the	  gas	  within	  the	  bubble	  to	  attain	  a	  very	  high	  temperature	  (5000	  K),	  
thereby	  producing	  large	  numbers	  of	  highly	  reactive	  free	  radicals.	  Inertial	  cavitation	  can	  also	  lead	  to	  
mechanical	  tissue	  disruption	  due	  to	  micro-­‐streaming	  and	  jetting,	  which	  has	  been	  associated	  with	  
petechial	  hemorrhage.	  The	  threshold	  pressures	  were	  predicted	  under	  the	  following	  assumptions:	  (1)	  
bubble	  present	  of	  optimal	  diameter12;	  (2)	  	  water/blood	  around	  bubble12;	  (3)	  a	  pulse	  duration	  of	  only	  1	  
period12;	  and	  (4)	  the	  use	  of	  a	  single	  derating	  factor	  for	  all	  imaging	  scenarios.13.	  Applying	  their	  findings,	  
they	  proposed	  a	  threshold	  of	  0.7	  for	  their	  ”mechanical	  energy	  index.”12.	  It	  is	  interesting	  to	  note	  that	  this	  
is	  below	  the	  pre-­‐1976	  established	  levels	  (ie,	  MI	  =	  1.9).	  	  In	  the	  following	  sections,	  the	  assumptions	  
employed	  during	  the	  original	  development	  of	  the	  MI	  have	  been	  extended	  to	  include	  more	  realistic,	  yet	  
also	  more	  complex	  parameters.	  
Viscoelasticity:	  The	  MI	  was	  developed	  based	  on	  an	  assumption	  of	  preexisting	  bubbles	  in	  liquids	  (water	  
and	  blood);	  however,	  most	  soft	  tissues	  are	  viscoelastic	  materials.	  As	  shown	  in	  Figure	  1A,	  the	  theoretical	  
threshold	  for	  inertial	  cavitation	  increases	  by	  a	  factor	  of	  2	  or	  more	  at	  all	  frequencies	  when	  comparing	  	  
that	  for	  water	  with	  corresponding	  thresholds	  in	  soft	  tissues.14,15	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Figure	  1.	  	  Theoretical	  thresholds	  for	  inertial	  cavitation	  of	  optimally	  sized	  air	  bubbles	  in	  materials	  with	  various	  viscoelastic	  
properties	  for	  a	  threshold	  criterion	  of	  Tmax	  =	  5000	  K.	  A,	  Thresholds	  calculated	  assuming	  pressure	  durations	  of	  1	  acoustic	  period.	  
B,	  Normalized	  (by	  data	  from	  1	  acoustic	  period	  in	  A)	  thresholds	  for	  inertial	  cavitation	  in	  each	  material	  at	  a	  pulse	  length	  of	  100	  
acoustic	  periods.	  Curves	  are	  the	  best	  fits	  of	  Pt	  =	  Bfc
n	  to	  the	  numerical	  data	  for	  water	  (•)	  blood	  (O),	  heart	  (£),	  kidney	  (¢),	  liver	  
(s),	  skeletal	  muscle	  (p),	  and	  skin	  (É).	  The	  average	  value	  for	  n	  (the	  power	  of	  frequency)	  for	  the	  combined	  curves	  was	  0.75.15	  
Pulse	  Duration:	  An	  assumption	  of	  a	  single	  acoustic	  period	  was	  made	  during	  the	  development	  of	  the	  MI.	  
While	  this	  is	  applicable	  to	  many	  ultrasonic	  imaging	  modes	  available	  on	  diagnostic	  scanners,	  including	  
harmonic	  imaging	  modes,	  some	  Doppler	  modes	  employ	  pulse	  durations	  of	  between	  10	  and	  20	  acoustic	  
periods,	  and	  acoustic	  radiation	  force	  impulse	  (ARFI)	  pulses	  are	  typically	  several	  hundred	  acoustic	  
periods.	  The	  effect	  of	  increasing	  pulse	  length	  from	  1	  to	  tens	  of	  acoustic	  periods	  is	  to	  reduce	  the	  
cavitation	  threshold	  for	  most	  bubbles.	  However,	  increasing	  pulse	  lengths	  above	  about	  100	  periods	  does	  
not	  further	  reduce	  the	  threshold.15,16	  Figure	  1B	  portrays	  thresholds	  for	  cavitation	  determined	  assuming	  
100	  acoustic	  periods	  of	  insonation	  that	  have	  been	  normalized	  by	  their	  corresponding	  values	  shown	  in	  
Figure	  1A	  for	  1	  acoustic	  period.15	  The	  impact	  is	  more	  significant	  in	  water	  and	  blood,	  whereas	  in	  soft	  
tissues,	  the	  thresholds	  remain	  within	  95%	  of	  those	  at	  1	  period.	  
Frequency:	  The	  MI	  currently	  employs	  a	  frequency	  power-­‐law	  dependence	  of	  f	  0.5,	  which	  was	  derived	  
assuming	  propagation	  through	  water	  or	  blood.	  Theoretical	  studies	  in	  viscoelastic	  materials	  indicate	  that	  
the	  frequency	  dependence	  of	  the	  threshold	  for	  inertial	  cavitation	  is	  better	  modeled	  by	  a	  factor	  of	  f0.75.15	  	  
Further,	  experimental	  evidence	  of	  cavitation-­‐mediated	  capillary	  damage	  in	  the	  presence	  of	  contrast	  
agents	  suggests	  that	  an	  exponent	  	  of	  1.0,	  rather	  than	  0.5,	  more	  accurately	  predicts	  a	  threshold	  for	  this	  
bioeffect.17	  
Single	  Derating	  Factor	  for	  All	  Imaging	  Scenarios:	  One	  of	  the	  significant	  challenges	  in	  the	  development	  
of	  acoustic	  output	  guidelines	  is	  estimating	  in	  vivo	  acoustic	  exposure	  due	  to	  the	  widely	  variable	  level	  of	  
signal	  loss	  encountered	  along	  the	  propagation	  path	  during	  imaging.	  The	  FDA	  guidance	  specifies	  that	  
acoustic	  output	  measurements	  be	  made	  in	  water,	  and	  derated	  by	  a	  factor	  (α) of	  0.3	  dB	  cm–1	  MHz–1	  	  to	  
account	  for	  frequency-­‐dependent	  attenuation	  in	  tissue	  when	  comparing	  new	  and	  pre-­‐1976	  device	  
output	  levels.5	  The	  selection	  of	  a	  single	  derating	  factor	  of	  0.3	  dB	  cm–1	  MHz–1	  	  was	  a	  compromise	  when	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the	  MI	  and	  TI	  were	  developed.13	  Several	  other	  models	  were	  considered,	  including	  the	  use	  of	  a	  factor	  of	  
0.5	  dB	  cm–1	  MHz–1	  for	  a	  known	  soft	  tissue	  propagation	  path.	  However,	  with	  the	  goal	  of	  maintaining	  
simplicity	  of	  implementation,	  the	  use	  of	  a	  single,	  conservative	  model	  was	  selected.	  In	  practice,	  a	  wide	  
range	  of	  energy	  levels	  occurs	  in	  vivo	  for	  a	  given	  system	  output	  due	  to	  differences	  in	  imaging	  location	  
and	  patient-­‐to-­‐patient	  variability	  in	  attenuation.	  For	  example,	  in	  all	  human	  transthoracic	  or	  
transabdominal	  examinations	  of	  internal	  organs,	  the	  ultrasound	  must	  pass	  through	  the	  body	  wall.	  	  For	  
both	  the	  intercostal	  space	  of	  the	  human	  thorax18	  and	  the	  abdominal	  wall,19,20	  the	  attenuation	  at	  the	  
body	  wall	  is	  about	  1.3	  dB	  cm–1	  MHz–1,	  which	  arises	  both	  from	  absorption	  and	  scattering.	  However,	  the	  
attenuation	  is	  highly	  variable,	  with	  about	  30%	  variation.21	  In	  addition,	  the	  thickness	  of	  the	  body	  wall	  
varies	  significantly	  among	  patients.	  As	  a	  result,	  a	  wide	  range	  of	  energy	  levels	  occurs	  in	  vivo	  for	  a	  given	  
system	  output,	  and	  the	  current	  derating	  approach	  likely	  overestimates	  actual	  in	  situ	  acoustic	  energy	  
levels	  in	  many	  cases,	  particularly	  for	  patients	  with	  larger	  body	  habitus.	  
3 Challenges	  With	  Estimation	  of	  In	  Situ	  Pressures	  
Because	  of	  differences	  in	  tissue	  acoustic	  attenuation,	  sound	  speed,	  and	  nonlinearity,	  the	  wide	  range	  of	  
energy	  levels	  that	  occur	  cannot	  be	  easily	  predicted	  from	  water-­‐based	  measurements.	  There	  are	  many	  
clinical	  imaging	  scenarios	  in	  which	  the	  current	  derating	  scheme	  overestimates	  in	  situ	  exposures,	  given	  
that	  α = 0.3	  dB	  cm–1	  MHz–1	  represents	  a	  conservative	  estimate	  for	  the	  reported	  attenuation	  of	  many	  soft	  
tissues.22	  	  The	  value	  of	  0.3	  dB	  cm–1	  MHz–1	  was	  a	  compromise	  between	  lower	  amniotic	  fluid	  values	  and	  an	  
average	  value	  of	  0.5	  dB	  cm–1	  MHz–1	  for	  soft	  tissues.	  The	  use	  of	  either	  higher	  average	  derating	  factors	  or	  
layered	  derating	  schemes	  to	  account	  for	  the	  increased	  energy	  loss	  in	  the	  body	  wall	  has	  been	  considered.	  
However,	  in	  some	  imaging	  scenarios,	  due	  in	  large	  part	  to	  saturation	  effects	  in	  water,	  the	  current	  
derating	  scheme	  can	  also	  lead	  to	  underestimation	  of	  in	  situ	  exposures,	  particularly	  for	  the	  cases	  of	  
higher-­‐frequency	  and	  f-­‐number	  focal	  configurations23,24	  (Figure	  2).	  	  It	  is	  also	  possible,	  although	  rare,	  that	  
an	  ultrasound	  beam	  would	  be	  focused	  substantially	  more	  sharply	  in	  inhomogeneous	  tissues	  than	  the	  
beams	  assumed	  in	  the	  calculations	  of	  the	  MI	  and	  TI,	  resulting	  in	  higher	  pressures	  and	  intensities	  in	  situ	  
than	  would	  otherwise	  be	  expected.	  For	  example,	  reflection	  from	  the	  concave	  surface	  of	  the	  pleura/lung	  
interface	  or	  transmission	  through	  a	  convex,	  symmetric	  fat	  lobule	  might	  focus	  a	  beam	  at	  a	  shorter	  depth	  
than	  intended.	  The	  accurate	  estimation	  of	  in	  situ	  exposure	  remains	  a	  significant	  challenge	  in	  ultrasonic	  
imaging,	  without	  a	  clear	  solution.	  	  Some	  proposed	  approaches	  are	  described	  below.	  
Effective	  Mechanical	  Index:	  In	  many	  research	  articles,	  investigators	  report	  an	  effective	  mechanical	  
index	  (MIE25–27)	  in	  addition	  to	  or	  instead	  of	  the	  MI.	  This	  concept	  represents	  an	  attempt	  to	  accurately	  
characterize	  in	  situ	  acoustic	  pressures.	  The	  MIE	  approach	  employs	  the	  estimated	  in	  situ	  pr	  in	  the	  
numerator	  of	  Equation	  1,	  rather	  than	  using	  a	  derating	  factor	  of	  0.3	  dB	  cm–1	  MHz–1	  as	  specified	  by	  the	  
FDA	  guidance	  and	  the	  International	  Electrotechnical	  Commission	  (IEC).10	  The	  MIE	  is	  useful	  because	  it	  
provides	  a	  more	  calibrated	  reference	  for	  comparison	  of	  the	  actual	  in	  situ	  values	  of	  pr	  associated	  with	  
cavitation-­‐mediated	  bioeffects	  in	  different	  experimental	  protocols,	  for	  which	  the	  prefocal	  losses	  are	  
often	  not	  accurately	  modeled	  by	  an	  attenuation	  factor	  of	  0.3	  dB	  cm–1	  MHz–1.	  The	  MIE	  is	  thus	  more	  
indicative	  of	  absolute	  safety	  thresholds,	  in	  contrast	  to	  the	  MI,	  which	  currently	  enables	  comparison	  with	  
pre-­‐1976	  output	  levels.	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There	  is	  not,	  however,	  a	  current	  consensus	  on	  a	  method	  to	  quantify	  MIE.	  In	  Church	  et	  al,28	  the	  following	  
method	  was	  recommended	  for	  estimation	  of	  MIE	  when	  the	  	  MI	  is	  provided.	  Given	  an	  MI	  value,	  the	  
water	  value	  of	  pr	  is	  estimated	  by	  correcting	  for	  frequency-­‐dependent	  derating	  utilizing	  the	  focal	  length	  F	  
(cm)	  and	  transducer	  center	  frequency	  fc	  	  (MHz)	  as	  follows:    !! = !!.!!"  !!!! !!!".	  Then,	  to	  estimate	  a	  
derated	  	  pr	  at	  another	  location,	  this	  back-­‐calculated	  water	  value	  is	  derated	  by	  the	  attenuation	  along	  the	  
new	  path	  length	  and	  divided	  by	   cf 	  	  to	  estimate	  an	  approximate	  derated	  MIEa	  at	  a	  site,	   .	  
This	  estimate	  can	  be	  easily	  implemented	  from	  the	  selected	  focal	  depth	  and	  knowledge	  of	  the	  
attenuation	  along	  the	  tissue	  path.	  Note	  that	  this	  is	  a	  simplification;	  the	  more	  accurate	  way	  of	  calculating	  
MIE	  would	  be	  to	  derate	  the	  original	  measured	  water	  value	  pr(z)	  for	  the	  attenuation	  along	  the	  tissue	  path	  
( , )f zα 	  and	  find	  the	  maximum	  value	  as	  !"# = !"#$!%![!! ! !!!.!!"! !!,! /   !!].	  In	  general,	  
0( , )
yf z f zα α= 	  for	  each	  tissue	  path	  segment	  along	  z,	  α0	  is	  in	  dB	  cm–1	  MHz–y,	  where	  y	  is	  an	  
exponent	  appropriate	  to	  the	  selected	  tissue,	  and	  z	  is	  the	  distance	  from	  the	  source.	  While	  this	  approach	  
enables	  MIE	  estimation	  for	  tissues	  with	  different	  attenuation	  values,	  it	  does	  not	  address	  challenges	  in	  
acoustic	  output	  characterization	  introduced	  by	  nonlinear	  propagation	  in	  water.	  
Nonlinear	  Propagation	  and	  Output	  Characterization:	  Figure	  2	  provides	  examples	  of	  several	  
investigative	  approaches	  that	  have	  been	  employed	  to	  account	  for	  nonlinearity	  and	  saturation	  effects	  in	  
the	  estimation	  of	  MIE	  for	  a	  range	  of	  imaging	  configurations.	  One	  approach	  is	  to	  perform	  measurements	  
in	  lossy	  media	  to	  more	  closely	  match	  in	  vivo	  imaging.29,30	  This	  approach	  was	  used	  to	  obtain	  the	  green	  
lines	  in	  Figure	  2,	  using	  a	  modified	  attenuating	  fluid	  recipe	  (evaporated	  milk	  and	  water).	  Challenges	  of	  
this	  approach	  include	  establishing	  a	  standard	  medium	  with	  specific	  acoustic	  properties,	  calibrating	  and	  
maintaining	  the	  hydrophone	  in	  the	  new	  medium,	  and	  satisfying	  the	  need	  for	  ease	  of	  maintenance	  and	  
repeatability	  (as	  water	  does),	  which	  would	  be	  required	  for	  commercial	  implementation.	  
A	  second	  approach	  is	  to	  develop	  an	  approximate	  multiplier	  to	  convert	  waves	  measured	  in	  water	  to	  
those	  generated	  in	  tissue.31–33	  A	  specific	  example	  in	  IEC	  Technical	  Specification	  IEC	  TS	  6194934	  (see	  
Appendix	  A)	  specifies	  extrapolating	  measurements	  from	  the	  “quasilinear”	  region	  in	  water	  to	  the	  
nonlinear	  region,	  so	  that	  linear	  tissue	  attenuation	  models	  can	  be	  more	  accurately	  applied.	  While	  this	  
approach	  reduces	  the	  likelihood	  of	  underestimation,	  it	  can	  lead	  to	  considerable	  overestimation	  of	  actual	  
in	  situ	  values,	  since	  it	  ignores	  nonlinear	  losses	  that	  occur	  in	  lossy	  media	  (Figure	  2,	  red	  lines).	  A	  twist	  on	  
this	  approach	  useful	  to	  both	  shocked	  and	  unshocked	  waves,	  but	  only	  for	  focused	  sources	  where	  it	  can	  
be	  assumed	  nonlinear	  effects	  are	  concentrated	  in	  a	  small	  portion	  of	  the	  tissue	  pathway,	  is	  to	  empirically	  
develop	  a	  lookup	  table	  between	  input	  values	  and	  focal	  waveforms	  in	  water	  and	  then	  use	  the	  standard	  
attenuation	  times	  focal	  distance	  loss,	  e–0.115αz,	  to	  derate	  the	  input	  source	  value	  and	  look	  up	  the	  
corresponding	  focal	  waveform.35	  The	  input	  value	  may	  be	  pressure,	  voltage,	  power,	  etc,	  at	  the	  source.	  
From	  the	  waveform,	  relevant	  acoustic	  parameters,	  MIE,	  intensity,	  etc,	  are	  obtained.	  	  	  
A	  third	  approach,	  described	  in	  greater	  detail	  in	  Appendix	  B,	  is	  to	  attempt	  to	  make	  the	  simplest,	  most	  
robust,	  and	  reproducible	  measurement	  in	  water	  and	  then	  use	  that	  information	  with	  a	  numerical	  model	  
to	  calculate	  the	  acoustic	  waveform	  in	  a	  specific	  tissue	  pathway	  in	  a	  3-­‐dimensional	  (3D)	  volume36–42	  
car, / fp
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(Figure	  2,	  left	  plot,	  black	  and	  green	  squares).	  The	  specific	  method	  described	  in	  IEC	  Technical	  
Specification	  	  IEC	  TS	  62556,	  Appendices	  E–G,43	  describes	  one	  measurement	  in	  a	  plane	  and	  acoustic	  
holography	  for	  simulation	  using	  a	  numerical	  model	  of	  the	  3D	  nonlinear	  acoustic	  field	  in	  situ.	  The	  
technique	  is	  a	  straightforward	  single	  measurement	  in	  water	  at	  a	  low	  output	  level	  under	  quasilinear	  
conditions	  (as	  determined	  by	  a	  “quasilinear”	  criterion	  described	  in	  IEC	  TS	  6194934)	  and	  numerical	  
calculation	  with	  well-­‐established	  models.	  The	  challenges	  are	  details	  of	  the	  measurement	  to	  collect	  
magnitude	  and	  phase,	  time	  to	  collect	  a	  raster-­‐scanned	  surface	  of	  data,	  and	  validation	  of	  the	  specific	  
numerical	  tools.	  Details	  on	  adequate	  sampling	  and	  the	  numerical	  calculations	  and	  checkpoints	  are	  
provided	  in	  IEC	  TS	  62556.43	  	  The	  advantages	  of	  this	  approach	  include	  a	  minimum	  number	  of	  
measurements	  to	  characterize	  the	  entire	  acoustic	  field,	  a	  capability	  to	  simulate	  propagation	  in	  
homogeneous	  absorbing	  tissue	  layers,	  and	  the	  faithful	  simulation	  of	  propagation	  from	  imperfect,	  
flawed,	  or	  asymmetric	  transducers.	  The	  same	  data	  can	  be	  used	  for	  linear	  simulation34	  or	  nonlinear	  
simulation,42	  as	  summarized	  in	  Appendix	  B.	  	  	  
Figure	  2	  portrays	  measurements	  obtained	  with	  3	  typical	  diagnostic	  transducers	  over	  a	  range	  of	  transmit	  
voltages	  processed	  using	  several	  of	  the	  methods	  described	  above	  to	  estimate	  in	  situ	  exposure.	  For	  these	  
examples,	  derating	  the	  water	  measurements	  by	  0.3	  dB	  cm–1	  MHz–1	  provided	  a	  reasonable	  approximation	  
to	  the	  pr	  measured	  in	  the	  milk	  solution,	  whereas	  using	  an	  attenuation	  of	  0.5	  dB	  cm–1	  MHz–1	  (ie,	  the	  
measured	  attenuation	  of	  the	  milk	  solution)	  for	  derating	  the	  water	  measurements	  considerably	  
underestimates	  the	  milk	  measurements.	  This	  is	  due	  to	  excess	  energy	  loss	  in	  water	  in	  the	  prefocal	  region	  
arising	  from	  nonlinear	  propagation	  in	  the	  water.	  Figure	  2	  also	  portrays	  the	  linearly	  extrapolated	  water-­‐
derated	  values	  (as	  described	  in	  Appendix	  A),	  indicating	  that	  extrapolation	  works	  reasonably	  well	  at	  
lower	  frequencies	  to	  approximate	  the	  milk	  measurements;	  however,	  it	  can	  significantly	  overestimate	  
the	  values	  in	  milk	  for	  the	  higher	  frequency	  transducers	  (VF7-­‐3	  and	  VF10-­‐5)	  at	  the	  higher	  transmit	  
voltages.	  This	  is	  because	  nonlinear	  losses	  in	  the	  milk	  increase	  with	  increasing	  frequency,	  and	  these	  
losses	  are	  not	  modeled	  by	  the	  linear	  extrapolation	  approach	  described	  in	  Appendix	  A.	  Most	  tissues	  have	  
a	  frequency	  exponent	  greater	  than	  the	  value	  1	  used	  for	  derating	  here,	  and	  a	  nonlinear	  parameter	  B/A	  
greater	  than	  that	  of	  water19;	  therefore,	  larger	  disagreement	  between	  data	  and	  derating	  schemes	  for	  
tissue	  can	  be	  expected.	  Furthermore,	  water	  is	  a	  highly	  nonlinear	  medium	  with	  negligible	  absorption;	  
therefore,	  measured	  pressure	  waveforms	  in	  water	  are	  usually	  highly	  distorted	  before	  derating.33	  A	  more	  
accurate	  method	  for	  simulating	  highly	  nonlinear	  propagation	  in	  absorbing	  media	  and	  water	  combines	  
hydrophone	  measurements	  to	  create	  an	  effective	  source	  field	  distribution,	  which	  is	  then	  used	  as	  an	  
input	  to	  a	  full	  nonlinear	  propagation	  simulation	  model	  capable	  of	  calculating	  the	  3D	  in	  situ	  field	  as	  
described	  in	  Appendix	  B.	  This	  approach	  has	  been	  used	  to	  simulate	  accurately	  the	  fields	  of	  a	  therapeutic	  
array	  for	  pressures	  up	  to	  100	  MPa.42	  The	  black	  and	  green	  squares	  in	  the	  leftmost	  plot	  of	  Figure	  2	  were	  
computed	  using	  a	  measured	  grid	  of	  hydrophone	  data	  at	  a	  plane	  near	  the	  transducer	  surface,	  which	  was	  
used	  as	  input	  to	  a	  full,	  3D	  nonlinear	  KZK	  forward	  propagation	  simulation	  (with	  numerical	  solution	  
methods	  described	  by	  Pinton44)	  to	  provide	  focal	  pressure	  estimates	  which	  were	  in	  good	  agreement	  with	  
the	  milk	  solution	  measurements.	  A	  simpler	  alternative	  is	  to	  combine	  average	  pressure	  waveforms	  over	  
the	  source	  (or	  at	  the	  focal	  point)	  at	  low	  drive	  levels	  and	  knowledge	  of	  the	  effective	  focusing	  geometry	  
with	  a	  nonlinear	  field	  simulator.45	  In	  summary,	  combined	  measurement/simulation	  methods	  that	  
facilitate	  accurate	  in	  situ	  MIE	  estimates	  including	  nonlinear	  effects	  are	  now	  becoming	  available.	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Figure	  2.	  Peak	  rarefactional	  pressure	  (p )	  values	  measured	  in	  water	  (r x)	  and	  derated	  by:	  0.3	  dB	  cm MHz 	  (–1	   –1 x),	  and	  0.5	  dB	  cm–1	  
MHz–1	  (x);	  	  pr	  derated	  water	  measurements	  linearly	  extrapolated	  from	  small	  signal	  values	  ((–),	  see	  appendix	  A);	  pr	  estimated	  
using	  a	  grid	  of	  source	  pressure	  measurements	  in	  water	  and	  modeling	  nonlinear	  propagation	  using	  the	  3D	  KZK	  model	  with	  
numerical	  solution	  methods	  described	  previously44	  (CH4-­‐1	  only)	  assuming	  propagation	  through	  	  water	  	  (¢)	  and	  milk	  (¢);	  as	  well	  
as	  in	  situ	  	  pr	  measurements	  made	  in	  an	  evaporated	  milk	  solution	  ((•),	  measured	  attenuation	  =	  0.5	  dB	  cm–1	  MHz–1).	  	  Note	  that	  
derating	  water	  values	  by	  0.3	  dB	  cm–1	  MHz–1	  provides	  reasonable	  agreement	  with	  the	  milk	  measurements	  (to	  within	  20%	  for	  all	  
transducers);	  however,	  derating	  water	  values	  by	  the	  actual	  measured	  attenuation	  of	  the	  milk	  (0.5	  dB	  cm–1	  MHz–1)	  leads	  to	  
considerable	  underestimation	  of	  the	  milk	  measurements.	  Additionally,	  the	  linear	  extrapolation	  approach	  considerably	  
overestimates	  the	  milk	  measurements	  for	  the	  higher	  frequency	  transducers,	  whereas	  the	  source	  pressure	  +	  nonlinear	  
simulation	  approach	  (black	  squares	  and	  green	  squares,	  left	  plot)	  is	  in	  good	  agreement	  with	  the	  milk	  measurements.	  Each	  array	  
transducer	  was	  focused	  with	  an	  F/2	  lateral	  focal	  configuration	  concurrent	  with	  its	  fixed	  elevation	  focus.	  
4 Experimental	  Evidence	  of	  Bioeffects	  for	  Relevant	  CIP	  Levels	  in	  Nonfetal	  
Tissues	  Not	  Known	  to	  Contain	  Gas	  Bodies	  
A	  fundamental	  assumption	  used	  to	  derive	  the	  MI	  is	  the	  presence	  of	  a	  bubble	  of	  optimal	  diameter	  to	  
serve	  as	  a	  cavitation	  nucleus.	  In	  most	  mammalian	  tissues,	  endogenous	  cavitation	  nuclei	  (ie,	  bubbles)	  are	  
rare, 	  which	  invalidates	  that	  assumption.	  More	  significantly	  for	  this	  report,	  if	  the	  insonification	  beam	  46
path	  excludes	  bubbles,	  then	  cavitation	  will	  not	  occur	  at	  the	  acoustic	  pressures	  contemplated	  for	  CIP	  
exposures.	  However,	  under	  some	  extraordinary	  conditions	  a	  bubble	  may	  be	  spontaneously	  nucleated.47	  
This	  occurs	  when	  gas	  comes	  out	  of	  solution,	  a	  process	  that	  takes	  place	  more	  readily	  at	  lower	  static	  
pressures;	  this	  is	  the	  reason	  the	  boiling	  temperature	  of	  water	  decreases	  with	  increasing	  elevation.	  The	  
acoustic	  pressure	  threshold	  for	  spontaneous	  nucleation	  of	  a	  bubble	  in	  water	  is	  predicted	  to	  be	  quite	  
high	  (30–100	  MPa),	  while	  the	  threshold	  in	  other	  materials	  depends	  on	  the	  interfacial	  tension.	  In	  certain	  
unusual	  cases,	  the	  nucleation	  threshold	  can	  approach	  the	  threshold	  value	  for	  cavitation	  of	  a	  preexisting	  
bubble,	  or,	  more	  usually,	  it	  can	  be	  more	  than	  twice	  this	  threshold.47	  In	  all	  cases	  studied,	  the	  nucleation	  
threshold	  is	  essentially	  independent	  of	  frequency	  while	  the	  threshold	  for	  inertial	  cavitation	  is	  predicted	  
to	  increase	  with	  frequency.47	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In	  2005,	  the	  AIUM	  convened	  a	  bioeffects	  conference,	  in	  which	  leading	  experts	  came	  together	  to	  review	  
and	  discuss	  bioeffects	  associated	  with	  diagnostic	  ultrasound.	  An	  excerpt	  from	  the	  summary	  of	  their	  
analysis	  in	  the	  context	  of	  the	  risk	  of	  non-­‐thermal	  bioeffects	  follows1:	  
“One	  of	  the	  primary	  mechanisms	  for	  nonthermal	  bioeffects	  is	  the	  interaction	  of	  ultrasound	  
fields	  with	  very	  small	  pockets	  of	  gas,	  referred	  to	  as	  gas	  bodies.	  There	  are	  locations	  within	  the	  
body	  that	  naturally	  harbor	  gas	  bodies,	  the	  most	  obvious	  being	  the	  lungs	  and	  intestines.	  In	  
addition,	  decompression	  sickness	  shows	  the	  possibility	  for	  generation	  of	  gas	  bodies	  in	  soft	  
tissue.	  	  As	  discussed	  by	  Church	  et	  al,48	  biological	  tissue	  is	  generally	  free	  of	  gas	  bodies,	  making	  
the	  likelihood	  of	  their	  interaction	  with	  ultrasound	  fields	  quite	  small;	  the	  potential	  of	  a	  clinically	  
significant	  biological	  effect	  from	  such	  interactions	  is	  smaller	  still.	  Additionally,	  for	  effects	  such	  as	  
the	  rapid	  growth	  and	  collapse	  of	  gas	  bodies,	  referred	  to	  as	  inertial	  cavitation,	  the	  fluid	  motion	  
induced	  by	  the	  gas	  bodies	  and	  other	  effects	  due	  to	  the	  ultrasound	  interactions	  are	  confined	  to	  a	  
small	  region	  immediately	  surrounding	  the	  gas	  bodies.	  Although	  a	  strategically	  placed	  gas	  body	  
could	  have	  a	  deleterious	  effect,	  this	  is	  statistically	  highly	  improbable.	  In	  experiments	  conducted	  
in	  tissues	  that	  are	  not	  known	  to	  contain	  well-­‐defined	  gas	  bodies,	  the	  requisite	  amplitude	  of	  the	  
ultrasound	  field	  for	  inducing	  bioeffects	  is	  relatively	  high;	  for	  example,	  10-­‐microsecond	  pulses	  of	  
1-­‐MHz	  ultrasound	  up	  to	  a	  peak	  rarefactional	  acoustic	  pressure	  of	  4	  MPa	  would	  not	  produce	  such	  
an	  effect.	  This	  is	  a	  rather	  low	  frequency	  and	  long	  pulse	  even	  for	  Doppler	  ultrasound,	  and	  to	  
provide	  some	  reference,	  the	  corresponding	  MI	  would	  be	  4.”	  	  	  
	  
The	  likelihood	  of	  such	  an	  effect	  associated	  with	  these	  parameters	  was	  estimated	  to	  be	  1	  in	  
10,000,000,000.48	  In	  this	  document,	  the	  general	  term	  "gas	  bodies"	  is	  used	  to	  remain	  consistent	  with	  
previous	  statements,	  reports,	  and	  publications	  from	  the	  AIUM;	  however,	  we	  also	  use	  the	  term	  
"bubbles"	  to	  mean	  pockets	  of	  gas	  on	  the	  order	  of	  micrometers	  or	  less.	  
As	  described	  in	  the	  following	  review,	  literature	  on	  this	  subject	  continues	  to	  support	  the	  conclusion	  that	  
in	  tissues	  without	  known	  gas	  bodies,	  ultrasound	  interactions	  with	  MIE	  values	  up	  to	  4	  would	  not	  be	  
expected	  to	  cause	  adverse	  cavitation-­‐mediated	  bioeffects.	  It	  should	  be	  noted	  that	  it	  is	  implicitly	  
assumed	  that	  any	  cavitation-­‐mediated	  bioeffect	  will	  be	  undesirable	  due	  to	  the	  very	  large	  concentration	  
of	  energy	  such	  events	  involve49;	  this	  is	  not	  true	  for	  other	  mechanisms.	  Although	  it	  is	  conceivable	  that	  
other	  nonthermal	  mechanisms	  may	  induce	  adverse	  bioeffects,	  none	  have	  been	  demonstrated	  to	  date,	  
and	  this	  possibility	  has	  not	  been	  as	  well	  studied.	  Radiation	  force	  was	  the	  subject	  of	  a	  recent	  review,50	  
and	  little	  cause	  for	  concern	  was	  expressed,	  except	  possibly	  for	  embryonic	  tissue.	  Recently,	  the	  safety	  
committee	  of	  the	  Japanese	  Society	  of	  Ultrasonics	  in	  Medicine	  started	  to	  investigate	  bioeffects	  induced	  
by	  ARFI	  ultrasound.	  They	  investigated	  temperature	  rise	  in	  tissue51–53	  and	  are	  planning	  to	  investigate	  
other	  potential	  bioeffects,	  including	  nonthermal	  effects.	  Some	  research	  suggests	  that	  some	  types	  of	  
exposures	  to	  specific	  tissues	  may	  be	  cause	  for	  concern54–56	  which	  is	  included	  in	  the	  discussion	  below.	  
4.1 Ultrasonic	  Stimulation	  of	  Bone	  Growth	  
Stimulation	  of	  bone	  growth	  is	  one	  of	  the	  earliest	  known	  bioeffects	  of	  ultrasound	  relevant	  to	  this	  topic.	  	  
In	  1954,	  Bender	  et	  al57	  reported	  osteogenesis	  within	  the	  marrow	  cavity	  of	  dog	  femurs	  exposed	  to	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relatively	  high	  powers	  (varying	  from	  5	  to	  20	  W,	  intensity	  not	  reported),	  4	  weeks	  after	  the	  exposure;	  the	  
osteogenesis	  seemed	  to	  “grow”	  from	  osteotomies	  in	  the	  cortical	  bone.	  Later,	  Dyson	  and	  Brookes58	  
reported	  healing	  effects	  in	  rats	  with	  fibular	  fractures	  exposed	  for	  5	  minutes	  on	  4	  consecutive	  days	  to	  
pulsed	  wave	  ultrasound	  (2	  milliseconds	  on,	  8	  milliseconds	  off)	  with	  spatial-­‐average	  intensity	  of	  0.5	  
W/cm2	  operated	  at	  either	  1.5	  or	  3.0	  MHz.	  The	  threshold	  for	  stimulation	  of	  the	  healing	  of	  fractures	  is	  
much	  lower.	  Duarte59	  demonstrated	  that	  daily	  application	  of	  ultrasound	  (5-­‐microsecond	  bursts	  of	  
ultrasound	  at	  either	  1.65	  or	  4.93	  MHz	  and	  a	  pulse	  repetition	  frequency	  [PRF]	  of	  1.0	  kHz	  for	  20	  minutes,	  
50–60	  mW/cm2	  spatial-­‐average	  temporal-­‐average	  intensity	  [ISATA])	  in	  rabbits	  with	  midshaft	  fibular	  
osteotomies	  accelerated	  the	  healing	  process	  by	  a	  factor	  of	  1.7.	  Significantly,	  Reher	  et	  al60	  found	  that	  
while	  3-­‐MHz	  ultrasound	  pulsed	  with	  a	  duty	  factor	  of	  20%	  (2	  milliseconds	  on,	  8	  milliseconds	  off)	  and	  an	  
intensity	  of	  100	  mW/cm2	  ISATA	  caused	  bone	  growth	  acceleration	  in	  5-­‐day-­‐old	  mouse	  calvaria,	  higher	  
intensities	  did	  not.	  There	  is	  a	  commercially	  available	  therapeutic	  ultrasonic	  system	  (Exogen,	  Bioventus,	  
LLC	  ),	  that	  employs	  200-­‐microsecond	  bursts	  at	  1.5	  MHz,	  ISATA	  =	  30	  mW/cm2,	  and	  duty	  factor	  =	  0.2	  applied	  
for	  20	  minutes,	  which	  has	  been	  reported	  to	  accelerate	  bone	  healing	  by	  up	  to	  40%.61	  While	  the	  
mechanism	  for	  these	  effects	  remains	  unresolved,	  none	  seem	  to	  be	  adverse.	  
4.2 Human	  Sensing	  of	  Ultrasonic	  Radiation	  Force	  
Ultrasound	  can	  affect	  both	  the	  central	  nervous	  system	  (CNS)	  and	  the	  peripheral	  nervous	  system	  (PNS).	  
Gavrilov	  and	  Tsirulnikov62	  identified	  3	  main	  PNS	  responses	  to	  ultrasound:	  tactile,	  thermal,	  and	  pain.	  	  It	  
has	  been	  demonstrated	  in	  a	  variety	  of	  studies	  that	  human	  beings	  are	  capable	  of	  sensing	  exposure	  to	  
ultrasound.	  Carefully	  designed	  experiments62,63	  identified	  acoustic	  radiation	  force	  as	  the	  main	  
mechanism	  in	  tactile	  sensation	  of	  ultrasound.	  For	  example,	  subjects	  were	  able	  to	  perceive	  10-­‐	  to	  100-­‐	  
millisecond	  pulses	  of	  2-­‐MHz	  ultrasound	  emitted	  at	  approximately	  20	  W	  by	  a	  1-­‐cm	  transducer	  coupled	  to	  
the	  forearm64;	  the	  total	  radiation	  force	  was	  about	  13	  mN.	  Subjects	  were	  also	  able	  to	  detect	  2.2-­‐MHz	  
ultrasound	  administered	  to	  the	  fingertip	  in	  a	  single	  burst	  of	  10	  to	  100	  milliseconds	  above	  a	  threshold	  
force	  of	  3	  mN	  (power	  ≈ 2.3	  W)	  or	  administered	  repetitively	  in	  2.5-­‐millisecond	  bursts	  at	  a	  PRF	  of	  200	  Hz	  
above	  a	  threshold	  radiation	  force	  of	  0.5	  mN	  (power	  ≈	  0.4	  W).	  The	  ear	  can	  detect	  higher	  frequencies	  and	  
shorter	  pulses	  than	  the	  finger.	  For	  example,	  the	  threshold	  for	  detection	  of	  sinusoidally	  modulated	  
megahertz	  ultrasound	  by	  the	  ear	  varies	  with	  the	  frequency	  of	  modulation	  in	  a	  way	  similar	  to	  that	  in	  
which	  it	  responds	  to	  audible	  airborne	  sound,	  with	  a	  broad	  minimum	  (indicating	  a	  maximum	  sensitivity)	  
of	  about	  1	  W/cm2	  in	  the	  range	  from	  200	  to	  4000	  Hz.	  This	  corresponds	  to	  a	  radiation	  pressure	  of	  about	  7	  
Pa,	  and	  since	  this	  is	  much	  greater	  than	  the	  threshold	  for	  hearing	  airborne	  sound	  (about	  20	  µPa),	  the	  ear	  
was	  apparently	  detecting	  the	  audio-­‐frequency	  radiation	  force	  generated	  by	  the	  transmitted	  ultrasound	  
rather	  than	  the	  2.5-­‐MHz	  carrier	  wave.	  Fetuses	  have	  also	  responded	  to	  this	  kind	  of	  modulation.63	  
Although	  these	  and	  other	  reports62,65	  provide	  interesting	  examples	  of	  reversible	  biological	  effects	  of	  
acoustic	  radiation	  	  force,	  there	  appears	  to	  be	  little	  cause	  for	  concern	  from	  such	  mechanisms,	  except	  
possibly	  in	  embryonic	  tissue,	  which	  lacks	  the	  structural	  strength	  that	  develops	  in	  later	  fetal	  and	  adult	  
life.	  since	  the	  intercellular	  matrix	  has	  yet	  to	  develop.50	  
	  
4.3 Ultrasonic	  Brain	  Stimulation	  
The	  CNS	  can	  be	  affected	  by	  ultrasound	  through	  the	  mechanisms	  of	  neurostimulation	  and	  
neuromodulation.62,65–67	  Recent	  experiments	  indicate	  that	  finely	  focused	  ultrasound	  excites	  neural	  
responses	  in	  the	  retina,	  the	  most	  accessible	  part	  of	  the	  CNS.68	  A	  43-­‐MHz	  transducer	  focused	  on	  a	  
salamander	  retina	  did	  not	  directly	  activate	  retinal	  ganglion	  cells	  but	  instead	  stimulated	  the	  interneurons	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beyond	  the	  photoreceptors.	  Low-­‐intensity	  transcranial	  pulsed	  ultrasound	  (one	  100-­‐millisecond	  pulse	  at	  
320	  kHz,	  derated	  pressure	  estimated	  at	  0.35	  MPa,	  spatial-­‐peak	  temporal-­‐average	  intensity	  [ISPTA]	  13.5	  
mW/cm2)	  focused	  in	  the	  frontal	  eye	  field	  of	  the	  brain	  in	  awake	  monkeys	  caused	  a	  significant	  increase	  in	  
the	  latency	  period	  of	  antisaccade	  eye	  movements.69	  The	  investigation	  indicated	  that	  focused	  ultrasound	  
can	  modulate	  behavior	  in	  the	  waking	  brain	  of	  nonhuman	  primates.69	  In	  related	  experiments,	  a	  mouse	  
brain	  was	  modulated	  transcranially	  with	  both	  pulsed	  and	  continuous-­‐wave	  (CW)	  unfocused	  500-­‐kHz	  
ultrasound	  (spatial-­‐peak	  pulse-­‐average	  intensity	  [ISPPA]	  =	  0.01-­‐79.02	  W/cm2)	  delivered	  near	  the	  top	  of	  
the	  head.70	  Somatomotor	  twitches	  of	  all	  legs	  at	  once	  triggered	  by	  the	  ultrasound	  stimulation	  appeared	  
to	  be	  of	  the	  all-­‐or-­‐nothing	  type;	  ie,	  stronger	  stimulus	  intensities	  and	  durations	  increased	  the	  probability	  
of	  a	  motor	  response	  without	  affecting	  the	  duration	  or	  strength	  of	  the	  response.	  Others	  have	  also	  
succeeded	  in	  affecting	  the	  brain	  transcranially	  with	  ultrasound.71	  While	  higher	  intensities	  have	  shown	  
clear	  effects	  on	  nerves	  with	  no	  observed	  histological	  changes,72	  lower	  intensities	  are	  also	  being	  studied.	  
A	  recent	  review73	  specifically	  summarizes	  efforts	  using	  low-­‐intensity	  focused	  ultrasound	  for	  
neuromodulation	  and	  brain	  stimulation.	  Recent	  human	  studies	  have	  shown	  effects	  ranging	  from	  mood	  
improvements	  (GE	  LOGIQe	  system	  with	  an	  12L-­‐RS	  probe,	  8	  MHz,	  MI	  =	  0.7)74	  to	  changes	  in	  
electroencephalographic	  activity	  (0.5-­‐MHz	  pulsed	  ultrasound,	  ISPPA	  =	  23.87	  W/cm2,	  peak	  rarefactional	  
pressure	  =	  0.8	  MPa).75	  The	  neuromodulatory	  effect	  is	  confirmed	  to	  be	  mediated	  through	  mechanical	  
interaction	  with	  the	  tissue,76,77	  with	  evidence	  that	  the	  observed	  effects	  are	  proportional	  to	  the	  
cumulative	  radiation	  force.	  
	  
4.4 Cavitation-­‐Related	  Bioeffects	  
Almost	  every	  adverse	  nonthermal	  biological	  effect	  of	  diagnostically	  relevant	  ultrasound	  that	  has	  been	  
identified	  has	  been	  related	  to	  bubble	  activity	  of	  some	  kind.	  However,	  micrometer-­‐sized	  bubbles	  are	  
extremely	  rare	  in	  normal	  mammalian	  blood	  and	  tissues.	  Blood	  seems	  to	  be	  essentially	  free	  of	  bubbles.	  	  
For	  example,	  Gross	  et	  al78	  used	  a	  resonance-­‐bubble	  detector	  but	  did	  not	  detect	  cavitation	  bubbles	  in	  the	  
abdominal	  aortas	  of	  dogs	  during	  exposure	  of	  heart	  or	  aortic	  blood	  to	  0.5-­‐	  to	  1.6-­‐MHz	  CW	  ultrasound	  up	  
to	  16	  W/cm2	  (0.7	  MPa).	  Using	  a	  similar	  detector,	  they	  were	  also	  unsuccessful	  in	  attempts	  to	  identify	  
cavitation	  from	  left	  ventricular	  blood	  in	  dogs	  exposed	  to	  0.75-­‐	  and	  1.45-­‐MHz	  ultrasound	  up	  to	  1	  kW/cm2	  
(5.5	  MPa),79	  as	  reported	  by	  Williams	  et	  al.80	  Hwang	  et	  al81	  detected	  an	  increase	  in	  endothelial	  damage	  in	  
the	  auricular	  veins	  of	  rabbits	  exposed	  to	  500-­‐cycle,	  5-­‐Hz-­‐PRF	  pulses	  of	  1.13-­‐MHz	  ultrasound	  at	  a	  peak	  
rarefactional	  pressure	  of	  6.5	  MPa	  but	  no	  increase	  at	  a	  pr	  of	  3.3	  MPa;	  damage	  of	  endothelial	  cells	  is	  
correlated	  with	  inertial	  cavitation82	  Similar	  results	  were	  obtained	  in	  a	  replicate	  experiment	  using	  500-­‐
cycle	  pulses	  of	  1.17-­‐MHz	  ultrasound	  at	  a	  PRF	  of	  1	  Hz.83	  
Most	  cavitation-­‐related	  bioeffects	  that	  have	  been	  experimentally	  observed	  in	  tissues	  not	  known	  to	  
contain	  gas	  bodies	  are	  associated	  with	  lower	  frequencies	  and	  longer	  durations	  than	  would	  be	  employed	  
in	  CIP	  in	  either	  harmonic	  imaging	  or	  ARFI	  imaging.	  For	  example,	  Frizzell	  et	  al84	  investigated	  hind	  limb	  
paralysis	  in	  mouse	  neonates	  exposed	  to	  1-­‐MHz	  ultrasound	  with	  a	  10-­‐microsecond	  pulse	  duration	  and	  a	  
2.4-­‐second	  exposure	  duration	  at	  10°C,	  finding	  that	  the	  threshold	  pr	  for	  cavitational	  involvement	  in	  the	  
paralysis	  was	  greater	  than	  5.1	  MPa	  for	  a	  5-­‐kHz	  PRF;	  the	  threshold	  decreased	  as	  the	  PRF	  increased.	  	  
The	  sudden	  onset	  of	  subharmonic	  emissions,	  scattering,	  attenuation,	  and	  the	  rate	  of	  heating	  during	  
hyperthermia	  procedures	  in	  dog	  thigh	  muscle	  was	  used	  by	  Hynynen85	  to	  estimate	  the	  threshold	  for	  
inertial	  cavitation	  as	  about	  3.8	  MPa	  at	  0.6	  MHz,	  5.9	  MPa	  at	  1	  MHz,	  and	  9.5	  MPa	  at	  1.7	  MHz;	  the	  pulse	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length	  was	  1	  second	  in	  all	  cases.	  	  Vykhodtseva	  et	  al86	  used	  the	  onset	  of	  subharmonic	  emissions	  to	  
determine	  the	  cavitation	  threshold	  in	  rabbit	  brain	  as	  10.4	  MPa	  at	  0.94	  MHz	  and	  13.6	  MPa	  at	  1.72	  MHz	  
Cavitation-­‐related	  cardiomyocyte	  death	  using	  a	  pulsing	  regime	  of	  1.55	  MHz,	  2-­‐millisecond	  duration,	  and	  
a	  pr	  of	  8	  MPa	  (measured	  in	  water)	  has	  been	  reported	  by	  Miller	  et	  al.54	  Recently,	  Gateau	  et	  al	  have	  
reported	  the	  direct	  observation	  by	  ultra-­‐high-­‐speed	  ultrasound	  imaging	  of	  the	  nucleation	  of	  large	  
bubbles	  (ie,	  those	  able	  to	  persist	  for	  at	  least	  100	  microseconds)	  by	  2-­‐cycle	  pulses	  of	  0.66-­‐MHz	  focused	  
ultrasound	  in	  ex	  vivo	  thigh	  muscle87	  and	  in	  vivo	  brain88	  of	  sheep.	  The	  threshold	  pr’s	  were	  6.4	  MPa	  in	  the	  
former	  case	  and	  12.7	  MPa	  in	  the	  latter.	  The	  summary	  of	  these	  data	  given	  in	  Table	  1	  reveals	  a	  wide	  range	  
of	  actual	  threshold	  values,	  which	  could	  be	  attributed	  to	  differences	  in	  animal	  model,	  cavitation	  
detection	  methods,	  and	  tissue	  type.	  The	  lowest	  threshold,	  1.8	  MPa,	  occurs	  at	  a	  frequency	  of	  0.25	  MHz,	  
or	  MIE	  =	  3.8;	  this	  is	  below	  the	  usual	  diagnostic	  frequency	  range.	  The	  lowest	  value	  in	  the	  diagnostic	  
range,	  5.0	  MPa,	  is	  found	  at	  1.0	  MHz.	  This	  corresponds	  to	  an	  MIE	  of	  about	  5.0,	  or	  more	  than	  2½	  times	  the	  
current	  maximum	  MI	  in	  the	  guidance	  on	  substantial	  equivalence	  from	  the	  US	  FDA.	  The	  fact	  that	  the	  
experimental	  cavitation	  thresholds	  and	  the	  corresponding	  values	  of	  MIE	  are	  both	  much	  higher	  than	  their	  
equivalent	  theoretical	  values	  suggests	  that	  these	  tissues	  do	  not	  contain	  pre-­‐existing	  gas	  bubbles.	  
In	  cardiac	  imaging,	  premature	  ventricular	  contractions	  (PVCs)	  have	  been	  reported	  as	  a	  bioeffect	  that	  can	  
be	  associated	  with	  ultrasonic	  insonation,	  primarily	  in	  the	  presence	  of	  ultrasonic	  contrast	  agents	  and	  with	  
the	  use	  of	  elevated	  acoustic	  output	  levels.54,89,90	  In	  one	  study,	  in	  the	  absence	  of	  contrast	  agents,	  for	  5-­‐
millisecond	  pulses	  at	  1.2	  MHz,	  a	  minimum	  threshold	  of	  1.5	  MPa	  pr	  was	  required	  to	  induce	  PVCs	  in	  mice	  
(MIE	  =	  1.3).	  For	  shorter	  pulses	  (1	  millisecond),	  the	  threshold	  pr	  was	  3.0	  MPa	  (MIE	  =	  2.6),	  and	  these	  were	  
less	  effective	  at	  inducing	  PVCs	  than	  even	  lower-­‐pressure,	  longer-­‐duration	  pulses.89	  An	  earlier	  study	  of	  
PVC	  induction	  in	  frogs	  produced	  similar	  results.56	  These	  MIE	  thresholds	  are	  much	  lower	  than	  those	  
reported	  in	  Table	  1,	  when	  direct	  evidence	  of	  cavitation	  was	  quantified.	  Given	  this	  discrepancy,	  one	  
might	  hypothesize	  that	  cardiac	  tissue	  is	  more	  susceptible	  to	  bioeffects	  than	  other	  tissues,	  and/or	  that	  
the	  PVCs	  in	  these	  studies	  were	  mediated	  not	  by	  cavitation	  but	  by	  radiation	  force,	  which	  would	  be	  more	  
likely	  in	  mice	  than	  humans,	  since	  the	  entire	  murine	  heart	  was	  encompassed	  by	  the	  focused	  beam	  in	  
these	  studies.	  This	  is	  suggested	  by	  the	  threshold	  intensity	  versus	  pulse	  duration	  relationship	  for	  PVCs	  
and	  also	  by	  the	  strong	  evidence	  for	  radiation	  force	  as	  the	  mechanism	  for	  reduced	  aortic	  pressure	  in	  
frogs.91	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Table	  1.	  Summary	  of	  Experimentally	  Determined	  Cavitation	  Thresholds	  in	  Tissue	  
It	  is	  important	  to	  note	  that	  while	  the	  ratio	   car, / fp 	  has	  the	  same	  form	  as	  the	  MI,	  for	  many	  of	  these	  studies	  the	  propagation	  
path	  includes	  both	  water	  and	  tissue,	  and	  estimates	  were	  made	  to	  determine	  an	  accurate	  value	  of	  the	  attenuated	  pr,	  in	  situ.	  	  




Perhaps	  the	  most	  thorough	  examination	  of	  the	  effects	  of	  pulsed	  ultrasound	  on	  biological	  tissues	  was	  
that	  conducted	  over	  a	  period	  of	  many	  years	  at	  the	  University	  of	  Illinois.	  In	  the	  early	  1970s,	  several	  
studies	  were	  performed	  related	  to	  the	  safety	  of	  ultrasound,	  and	  thresholds	  for	  tissue	  damage	  were	  
evaluated	  for	  a	  variety	  of	  acoustic	  parameters	  in	  exposed	  feline	  brain.	  The	  values	  of	  the	  acoustic	  
parameters	  spanned	  the	  range	  from	  diagnostic	  to	  therapeutic	  output	  levels	  and	  frequencies.	  The	  
researchers	  divided	  the	  lesions	  that	  were	  generated	  into	  3	  categories	  (thermal,	  cavitation,	  and	  a	  
“combination”	  of	  effects,	  likely	  mechanical).93.94	  Through	  these	  studies,	  the	  authors	  found	  that	  the	  
threshold	  for	  lesion	  formation	  was	  related	  to	  in	  situ	  pulse	  intensity	  (I),	  exposure	  duration	  (t),	  and	  
frequency	  (f)	  by	   ( )fctI = ,	  where	  c(f)	  was	  an	  empirically	  derived	  threshold	  with	  a	  moderate	  frequency	  
dependence.95	  The	  acoustic	  intensities	  were	  quantified	  using	  linear	  extrapolation	  of	  small	  signal	  values	  
(in	  a	  manner	  similar	  to	  that	  discussed	  in	  	  Appendix	  A)	  to	  avoid	  saturation	  artifacts	  in	  the	  measurements,	  




















p  	  
Tissue	   Source	  
MHz	   µs	   –	   MPa	   dB	   MPa	   –	   –	   –	  
0.17	   58.8	   12000	   4.9	   0.3	   4.7	   11.5	   Pig	  kidney	   92	  
0.25	   1000000	   1*	   1.8	   0.0	   1.9	   3.8	   Dog	  muscle	   85	  
0.56	   1000000	   1*	   3.8	   0.0	   3.6	   4.8	   Dog	  muscle	   85	  
0.66	   3.0	   1–2	   6.4	   0.5	   6.0	   7.4	   Sheep	  muscle	   87	  
0.66	   3.0	   1–2	   12.7	   0.5	   12.0	   14.8	   Sheep	  brain	   88	  
0.94	   1000	   1	   10.4	   0.0	   10.4	   10.7	   Rabbit	  brain	   86	  
1.0	   10	   12000	   5.1	   0.1	   5.0	   5.0	   Mouse	  neonate	   84	  
1.0	   1000000	   1*	   5.9	   0.0	   5.9	   5.9	   Dog	  muscle	   85	  
1.13	   442.5	   60	   6.5	   0.1	   6.4	   6.0	   Rabbit	  blood	   81	  
1.17	   427.35	   120	   6.5	   0.1	   6.4	   5.9	   Rabbit	  blood	   83	  
1.5	   20	   1	   8.0	   1.2	   7.0	   5.7	   Rat	  heart	   54	  
1.5	   2000	   1	   8.0	   1.2	   7.0	   5.7	   Rat	  heart	   54	  
1.68	   1000000	   1*	   9.5	   0.0	   9.5	   7.3	   Dog	  muscle	   85	  
1.72	   1000	   1	   13.6	   0.0	   13.6	   10.4	   Rabbit	  brain	   86	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which,	  as	  shown	  in	  Figure	  2,	  can	  overestimate	  the	  actual	  in	  situ	  values,	  particularly	  for	  higher	  
frequencies.	  
Based	  on	  these	  studies,	  Dunn	  and	  Fry93	  reported	  that	  subthreshold	  pulses	  did	  not	  sum	  to	  produce	  a	  
suprathreshold	  functional	  effect	  unless	  the	  duty	  cycle	  was	  nearly	  one-­‐half	  and	  the	  pulse	  duration	  was	  10	  
milliseconds.	  In	  addition,	  they	  reported	  that:	  
“1100	  cats	  have	  been	  irradiated	  in	  the	  laboratory	  under	  procedures	  yielding	  10,000	  individual	  
exposures	  producing	  lesions	  in	  the	  adult	  cat	  brain	  in	  the	  ’focal	  region’	  of	  the	  dosage	  curve.	  All	  
animals	  were	  examined	  histologically	  in	  the	  focal	  region	  of	  the	  sound	  beam	  and	  in	  intervening	  
tissue	  between	  the	  focal	  region	  and	  the	  port	  of	  entry	  of	  the	  sound	  into	  the	  brain.	  It	  is	  pointed	  
out	  here	  that	  the	  intervening	  tissue	  received	  multiple	  doses	  ranging	  from	  just	  below	  threshold	  
values,	  near	  the	  beam	  focus,	  to	  much	  lesser	  values,	  at	  the	  cortex.	  Animal	  survival	  was	  allowed	  to	  
range	  from	  a	  few	  minutes	  to	  five	  years,	  with	  more	  than	  half	  being	  sacrificed	  between	  one	  and	  
two	  years	  after	  exposure.	  From	  all	  these	  data	  no	  evidence	  emerges	  suggesting	  tissue	  
abnormalities	  produced	  by	  the	  passage	  of	  sound	  through	  intervening	  tissue.”93	  
Although	  it	  is	  tempting	  to	  make	  use	  of	  these	  data	  for	  the	  purposes	  of	  this	  report,	  this	  would	  be	  difficult	  
to	  support	  scientifically.	  The	  research	  was	  not	  expressly	  aimed	  at	  studying	  cavitation	  in	  tissue,	  at	  least	  
not	  the	  type	  of	  cavitation	  the	  MI	  was	  designed	  to	  predict.	  That	  is,	  there	  were	  no	  measurements	  of	  
acoustic	  emissions	  specific	  to	  inertial	  cavitation;	  there	  was	  no	  search	  for	  the	  microlesions	  expected	  to	  be	  
produced	  by	  inertial	  cavitation	  at	  threshold	  exposures;	  the	   tI 	  dependence	  is	  puzzling	  (and	  is	  still	  not	  
understood,	  except	  possibly	  in	  the	  context	  of	  a	  thermal	  dose	  analysis96);	  the	  frequency	  dependence	  was	  
not	  that	  expected	  for	  cavitation;	  and	  the	  cavitation	  resulting	  from	  these	  exposures	  was	  not	  necessarily	  
at	  the	  focus.	  Further,	  the	  acoustic	  field	  measurements	  are	  difficult	  to	  compare	  to	  equivalent	  
measurements	  made	  using	  modern	  techniques.	  These	  difficulties	  make	  it	  challenging	  to	  place	  this	  work	  
in	  the	  context	  of	  the	  modern	  MI	  and	  TI	  scheme.	  
However,	  the	  work	  done	  at	  the	  University	  of	  Illinois	  is	  not	  without	  value	  for	  the	  subject	  herein.	  For	  
example,	  the	  data	  suggest	  that	  the	  duration	  of	  excitation	  has	  a	  significant	  impact	  on	  the	  cavitation	  
threshold.	  From	  a	  mechanistic	  point	  of	  view,	  the	  experimental	  results	  shown	  in	  Table	  1	  and	  from	  the	  
University	  of	  Illinois93–95	  suggest	  that	  the	  probability	  that	  exposure	  to	  diagnostic	  ultrasound	  (emitted	  by	  
devices	  cleared	  under	  current	  track	  3	  guidelines)	  will	  induce	  cavitation	  in	  tissue	  not	  containing	  
preexisting	  gas	  bodies	  is	  essentially	  zero.	  Further,	  given	  the	  apparently	  large	  safety	  margin	  provided	  by	  
the	  current	  FDA	  diagnostic	  ultrasound	  guidance97	  (under	  the	  assumption	  that	  the	  MI	  accurately	  reflects	  
in	  situ	  levels),	  it	  seems	  reasonable	  to	  suggest	  that	  exceeding	  the	  recommended	  maximum	  level	  given	  in	  
the	  guidance	  could	  be	  warranted	  if	  a	  significant	  increase	  in	  diagnostic	  information	  could	  be	  obtained	  
thereby.	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Figure	  3.	  Best	  estimates	  of	  in	  situ	  rarefactional	  pressure	  shown	  in	  Table	  1.	  Triangles	  and	  circles	  indicate	  values	  for	  brain	  and	  all	  
other	  tissues,	  respectively.	  Curves	  delineate	  pressures	  calculated	  for	  the	  maximum	  value	  of	  the	  MI	  in	  the	  FDA’s	  guidance	  for	  
track	  3	  devices	  (solid	  curve,	  labeled	  MI	  =	  1.9)	  and	  an	  effective	  mechanical	  index	  of	  4.0	  (dashed	  curve,	  labeled	  MIE	  =	  4.0).	  
The	  question	  of	  the	  extent	  to	  which	  the	  current	  recommended	  maximum	  should	  be	  exceeded	  is	  best	  
addressed	  by	  considering	  the	  data	  in	  Table	  1.	  	  A	  plot	  of	  the	  in	  situ	  cavitation	  threshold	  rarefactional	  
pressures	  as	  a	  function	  of	  frequency	  is	  given	  in	  Figure	  3.	  The	  values	  for	  all	  tissues	  other	  than	  brain	  are	  
shown	  as	  circles,	  while	  the	  three	  values	  for	  brain	  are	  the	  triangles.	  The	  physical	  characteristics	  of	  brain	  
seem	  to	  be	  different	  from	  those	  of	  the	  other	  tissues,	  thus	  leading	  to	  higher	  thresholds,	  but	  the	  nature	  of	  
the	  differences	  is	  not	  clear.	  The	  solid	  black	  curve	  labeled	  MI	  =	  1.9	  gives	  the	  in	  situ	  rarefactional	  pressure	  
at	  the	  upper	  end	  of	  the	  range	  in	  the	  guidance	  for	  track	  3	  devices:	   MHz/. 191 fpr = 	  MPa.	  The	  solid	  red	  
curve	  labeled	  MIE	  =	  4.0	  gives	  the	  proposed	  upper	  limit	  on	  pr	  for	  use	  during	  the	  exploratory	  phase	  of	  the	  
CIP	  process	  described	  below.	  Note	  that	  this	  curve	  passes	  through	  the	  lowest	  datum	  at	  0.25	  MHz	  (within	  
experimental	  error).	  This	  is	  the	  lowest	  experimentally	  determined	  in	  situ	  threshold	  value	  for	  
rarefactional	  pressure	  at	  any	  frequency,	  which	  justifies	  its	  use	  as	  a	  limit	  at	  this	  time.	  In	  addition,	  the	  
value	  of	  rarefactional	  pressure	  at	  1	  MHz	  is	  4.0	  MPa,	  which	  provides	  a	  safety	  margin	  of	  1.0	  MPa	  over	  the	  
lowest	  datum	  at	  that	  frequency;	  1.0	  MHz	  is	  sometimes	  cited	  as	  being	  at	  the	  lower	  end	  of	  typical	  
diagnostic	  frequencies.	  The	  MIE	  retains	  the	  frequency	  response	  of	  the	  MI,	  so	  the	  safety	  margin	  can	  be	  
expected	  to	  increase	  further	  as	  the	  acoustic	  frequency	  increases.	  	  	  
5 Imaging	  Scenarios	  Excluded	  From	  Consideration	  for	  CIP	  
5.1 Tissues	  Known	  to	  Contain	  Gas	  Bodies	  
Evidence	  from	  in	  vivo	  animal	  research	  shows	  that	  mechanical	  bioeffects	  can	  occur	  in	  tissues	  containing	  
gas	  bodies	  at	  outputs	  associated	  with	  in	  situ	  exposure	  levels	  well	  below	  an	  MI	  of	  1.9.	  Two	  situations	  of	  
concern	  have	  begun	  to	  be	  elucidated.	  First,	  the	  lung	  is	  susceptible	  to	  pulmonary	  hemorrhage	  induced	  by	  
diagnostic	  ultrasound55	  or	  laboratory	  pulsed-­‐ultrasound	  exposure	  approximating	  diagnostic	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ultrasound.28	  This	  effect	  is	  thought	  to	  be	  due	  to	  the	  interaction	  of	  the	  pulses	  with	  the	  alveolar	  gas.	  
Similar	  effects	  are	  seen	  near	  bowel	  gas,	  which	  are	  discussed	  in	  the	  fetal	  imaging	  section	  below.	  Second,	  
microbubbles	  in	  ultrasound	  contrast	  agents	  can	  nucleate	  ultrasonic	  cavitation	  during	  contrast-­‐enhanced	  
diagnostic	  ultrasound,	  leading	  to	  injury	  of	  tissue	  capillaries.98	  Both	  of	  these	  effects	  appear	  to	  have	  
threshold	  output	  levels	  for	  a	  given	  set	  of	  imaging	  conditions.	  Below	  the	  threshold,	  the	  risk	  appears	  to	  be	  
negligible,	  while	  the	  extent	  and	  severity	  of	  the	  effects	  increase	  rapidly	  with	  increasing	  output	  above	  the	  
threshold.	  
Lung	  Thresholds:	  Ultrasound	  induction	  of	  pulmonary	  hemorrhage	  may	  be	  characterized	  by	  threshold	  
output	  pressure	  amplitudes	  for	  various	  clinical	  ultrasound	  frequencies	  and	  other	  ultrasound	  parameters.	  
Thresholds	  for	  different	  animals	  and	  exposure	  conditions	  are	  similar	  and	  appear	  to	  increase	  with	  
ultrasound	  frequency.	  Average	  in	  situ	  thresholds	  range	  from	  about	  0.54	  MPa	  at	  1	  MHz	  	  (MI	  =	  0.54)	  to	  
about	  1.3	  MPa	  at	  4	  MHz	  (MI	  =	  0.63).99	  However,	  some	  studies	  in	  mice	  and	  pigs	  using	  laboratory	  
exposure	  systems	  indicated	  thresholds	  equivalent	  to	  MI	  =	  0.3–0.4.100	  A	  recent	  study	  in	  rats	  found	  a	  
threshold	  of	  about	  MI	  =	  0.44	  for	  diagnostic	  ultrasound	  at	  7.6	  MHz.55	  These	  empirical	  data	  have	  a	  
considerably	  different	  relationship	  between	  the	  threshold	  for	  damage	  and	  the	  MI,	  suggesting	  that	  the	  
development	  of	  a	  lung-­‐specific	  MI	  would	  be	  appropriate.	  
Ultrasonic	  Contrast	  Agent	  Thresholds:	  The	  induction	  of	  capillary	  hemorrhage	  by	  contrast-­‐enhanced	  
diagnostic	  ultrasound	  may	  be	  variable	  depending	  on	  the	  specific	  tissue,	  contrast	  agent,	  and	  ultrasound	  
mode.	  Little	  information	  is	  available	  to	  provide	  specific	  thresholds	  for	  all	  situations.	  However,	  testing	  
with	  presently	  available	  agents	  seems	  to	  show	  comparable	  bioeffects	  risks	  for	  different	  agents	  and	  
tissues.	  Studies	  of	  muscle	  tissue	  have	  shown	  thresholds	  of	  about	  MI	  =	  0.4	  for	  low	  diagnostic	  ultrasound	  
frequencies,98	  including	  rat	  spinotrapezius	  muscle	  at	  2.3	  MHz101	  and	  rat	  heart	  at	  1.7	  MHz	  using	  the	  
highest	  output	  level	  tested	  without	  capillary	  hemorrhage,	  0.54	  MPa,	  as	  the	  threshold.102	  One	  study	  of	  
glomerular	  capillary	  hemorrhage	  in	  rat	  kidney	  indicated	  that	  thresholds	  were	  approximately	  
proportional	  to	  0.5	  MPa	  times	  frequency	  from	  1.5–7.4	  MHz.17	  This	  frequency	  dependence	  is	  stronger	  
than	  that	  incorporated	  into	  the	  MI	  by	  an	  additional	  square-­‐root	  of	  the	  frequency.	  The	  World	  Federation	  
for	  Ultrasound	  in	  Medicine	  and	  biology	  (WFUMB)	  and	  European	  Federation	  of	  Societies	  for	  Ultrasound	  
in	  Medicine	  and	  Biology	  (EFSUMB),	  in	  coordination	  with	  the	  AIUM,	  recently	  issued	  a	  consensus	  
statement	  on	  the	  use	  of	  contrast	  enhanced	  diagnostic	  ultrasound,	  which	  addresses	  both	  recommended	  
output	  levels	  and	  the	  use	  of	  the	  ALARA	  principle	  in	  this	  setting.103	  
Given	  the	  reported	  potential	  for	  bioeffects	  in	  tissues	  known	  to	  contain	  gas	  bodies	  described	  above,	  and	  
the	  continuing	  efforts	  of	  the	  bioeffects	  community	  to	  address	  these	  concerns,	  these	  tissues	  have	  been	  
excluded	  from	  consideration	  for	  CIP	  as	  discussed	  herein.	  
5.2 Fetal	  Imaging	  
There	  are	  reports	  of	  increased	  fetal	  activity	  during	  diagnostic	  ultrasound	  imaging,	  which	  have	  been	  
attributed	  to	  radiation	  forces	  on	  the	  fetal	  head	  or	  auditory	  structures	  at	  PRFs	  within	  the	  auditory	  
frequency	  range.104	  Although	  this	  phenomenon	  has	  not	  been	  considered	  deleterious,104	  the	  radiation	  
forces	  generated	  by	  ARFI	  pulses	  are	  applied	  using	  pulse	  durations	  1–2	  orders	  of	  magnitude	  longer	  than	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those	  associated	  with	  conventional	  B-­‐mode/Doppler	  imaging.	  The	  impact	  of	  these	  longer-­‐duration	  
pulses	  on	  fetal	  activity	  is	  currently	  unknown.	  	  
In	  addition,	  while	  there	  is	  a	  body	  of	  literature	  indicating	  that	  ultrasound	  exposure	  of	  air-­‐filled	  lung	  and	  
intestine	  at	  diagnostic	  output	  levels	  can	  be	  associated	  with	  localized	  hemorrhage,	  fetal	  tissues	  do	  not	  
contain	  preexisting	  cavitation	  nuclei.	  There	  are	  no	  confirmed	  experimental	  studies	  with	  laboratory	  
animals	  showing	  a	  direct	  association	  between	  an	  adverse	  fetal	  biological	  effect	  and	  nonthermal	  
mechanisms	  from	  exposure	  to	  diagnostic	  ultrasound	  output	  levels.104	  Further,	  in	  studies	  of	  pregnant	  
mice,	  Hartmann	  et	  al105	  applied	  10	  lithotripter	  pulses	  at	  a	  peak	  positive	  pressure	  amplitude	  of	  20	  MPa,	  
far	  exceeding	  diagnostic	  levels,	  resulting	  in	  extensive	  hemorrhage	  in	  the	  air-­‐filled	  maternal	  lungs,	  but	  
there	  was	  	  no	  observable	  gross	  hemorrhage	  in	  the	  fluid-­‐filled	  fetal	  lungs.	  Similar	  findings	  were	  reported	  
for	  murine	  fetal	  intestine,106	  suggesting	  that	  CIP	  as	  discussed	  herein,	  specifically	  in	  the	  context	  of	  the	  
lack	  of	  preexisting	  cavitation	  nuclei	  in	  fetal	  imaging,	  	  would	  not	  be	  associated	  with	  elevated	  risk	  due	  to	  
cavitation.	  
However,	  there	  are	  reports	  of	  vascular	  damage	  in	  murine	  fetuses	  near	  developing	  bone	  for	  acoustic	  
output	  exceeding	  diagnostic	  levels	  but	  within	  the	  range	  of	  CIP	  proposed	  herein,	  albeit	  for	  a	  longer	  
imaging	  duration.	  In	  lithotripter	  fields	  with	  amplitudes	  less	  than	  1	  MPa,	  hemorrhages	  were	  reported	  
near	  developing	  bone	  in	  the	  head,	  limbs,	  lung,	  and	  ribs;	  no	  vascular	  damage	  was	  observed	  in	  murine	  
fetuses	  exposed	  at	  a	  gestation	  stage	  prior	  to	  bone	  formation.107	  In	  pulsed	  ultrasound,	  fetal	  hemorrhagic	  
damage	  near	  bone	  interfaces	  in	  late-­‐gestation	  mice	  was	  reported	  for	  3-­‐minute	  exposures	  to	  1	  MHz,	  10-­‐
microsecond,	  100-­‐Hz	  PRF	  beams	  with	  a	  threshold	  pr	  of	  2.5	  MPa,	  which	  corresponds	  to	  an	  MIE	  of	  2.5.108	  
Recently,	  several	  additional	  reports	  have	  suggested	  cause	  for	  concern	  regarding	  fetal	  imaging.	  Exposure	  
of	  chick	  brain	  to	  pulsed	  Doppler	  ultrasound	  (MI	  =	  0.48,	  ISPTA	  =	  576	  W	  cm–2)	  for	  4	  or	  5	  minutes	  at	  day	  19	  of	  
incubation	  was	  reported	  to	  impair	  memory	  in	  chicks	  at	  day	  2	  following	  hatching.109	  Rat	  fetuses	  exposed	  
to	  standard	  2-­‐dimensional	  imaging	  (13	  MHz,	  MI	  =	  0.71,	  ISPPA	  =	  222.4	  W	  cm–2)	  for	  from	  1	  to	  4	  sessions	  of	  
45	  to	  55	  seconds	  each	  on	  different	  days	  of	  gestation	  exhibited	  changes	  in	  the	  expression	  of	  some	  genes,	  
most	  notably	  those	  implicated	  in	  developmental	  signaling	  pathways.110	  Prenatal	  exposure	  of	  rat	  fetuses	  
to	  B-­‐mode	  ultrasound	  (2.89	  MHz,	  MI	  =	  1.1,	  spatial-­‐average	  pulse-­‐average	  intensity	  [ISAPA]	  =	  157	  mW	  cm–2)	  for	  1	  
or	  2	  hours	  per	  day	  for	  9	  days	  reportedly	  increased	  the	  permeability	  of	  the	  blood-­‐brain	  barrier	  on	  
postnatal	  day	  10	  but	  not	  later.111	  The	  acoustic	  mechanism	  responsible	  for	  these	  bioeffects	  is	  not	  yet	  
understood.	  
Taken	  together,	  these	  findings	  suggest	  that	  fetal	  imaging	  should	  be	  excluded	  from	  consideration	  for	  CIP	  
until	  further	  data	  are	  available.	  	  	  
6 Potential	  Clinical	  Benefit	  of	  CIP	  in	  Nonfetal	  Tissues	  Not	  Known	  to	  Contain	  
Gas	  Bodies	  
Among	  the	  new	  imaging	  techniques	  that	  often	  approach	  the	  maximum	  recommended	  acoustic	  output	  
levels	  are	  harmonic	  imaging	  modes112	  and	  ARFI-­‐based	  elasticity	  imaging	  modes.113,114	  In	  a	  subset	  of	  
patients,	  the	  diagnostic	  information	  obtained	  with	  these	  modalities	  can	  be	  limited	  by	  poor	  image	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quality.	  The	  causes	  can	  be	  wide	  ranging,	  including	  decreased	  signal	  strength	  due	  to	  intervening	  tissue	  
attenuation	  and	  increased	  noise	  generally	  attributed	  to	  clutter/reverberation	  and	  phase	  aberration.	  
Many	  creative	  approaches	  that	  operate	  within	  existing	  output	  guidelines	  have	  been	  developed	  to	  
address	  poor	  image	  quality,	  including,	  eg,	  synthetic	  aperture	  imaging,	  compounding,	  and	  tissue	  
harmonic	  imaging	  (see	  below).	  However,	  because	  of	  concerns	  regarding	  FDA	  clearance,	  systems	  have	  
not	  been	  engineered	  to	  exceed	  the	  established	  guidelines,	  and	  there	  are	  limited	  data	  available	  exploring	  
the	  potential	  benefits	  of	  imaging	  in	  this	  output	  regime.	  Initial	  discussion	  and	  findings	  for	  2	  imaging	  
modes	  that	  have	  the	  potential	  to	  benefit	  from	  elevated	  output	  are	  discussed	  below.	  
6.1 B-­‐Mode/Tissue	  Harmonic	  Imaging	  
Tissue	  harmonic	  imaging	  (THI)	  involves	  acoustic	  transmission	  at	  one	  frequency	  and	  image	  formation	  at	  
the	  second	  harmonic	  (twice	  the	  transmission	  frequency).115	  The	  advantages	  of	  THI	  are	  based	  on	  
improvements	  in	  image	  quality	  in	  the	  presence	  of	  phase	  aberration	  and	  clutter,	  and	  since	  its	  
introduction	  in	  the	  late	  1990s,	  this	  imaging	  mode	  has	  become	  ubiquitous	  in	  clinical	  imaging.	  However,	  
due	  to	  the	  relatively	  weak	  signal	  as	  compared	  to	  the	  fundamental	  frequency	  (typically	  –20	  dB),	  THI	  
modes	  often	  have	  limited	  depth	  penetration	  in	  many	  imaging	  scenarios.	  
For	  both	  conventional	  B-­‐mode	  and	  harmonic	  imaging,	  higher	  transmit	  power	  will	  increase	  the	  scattered	  
signal	  level,	  thus	  increasing	  the	  signal-­‐to-­‐noise	  ratio	  (SNR)	  and	  concurrently	  increasing	  the	  depth	  of	  
penetration.	  For	  conventional	  B-­‐mode	  imaging,	  however,	  the	  predicted	  gains	  are	  not	  significant:	  in	  one	  
analysis,	  only	  a	  6%	  increase	  in	  depth	  of	  penetration	  is	  estimated	  for	  a	  40%	  increase	  in	  transmit	  
intensity.116	  For	  harmonic	  imaging,	  the	  improvement	  with	  increased	  transmit	  power	  can	  be	  appreciable,	  
since	  the	  production	  of	  harmonics	  is	  proportional	  to	  the	  square	  of	  the	  pressure	  at	  the	  fundamental	  
frequency	  of	  the	  transmit	  wave.115	  Thus,	  a	  3-­‐dB	  increase	  in	  the	  fundamental	  will	  result	  in	  a	  6-­‐dB	  increase	  
in	  harmonic	  intensity.	  
The	  amount	  of	  harmonic	  that	  is	  produced	  and	  eventually	  received	  by	  the	  transducer	  is	  dependent	  on	  
the	  transmit	  power,	  the	  focal	  zone	  location,	  the	  distance	  the	  wave	  travels	  inside	  the	  tissue,	  the	  
transducer	  bandwidth,	  system	  signal	  processing,	  and	  the	  tissue	  properties.	  Figure	  4	  provides	  a	  
comparison	  of	  simulations	  run	  for	  a	  typical	  curvilinear	  abdominal	  imaging	  array,	  operating	  in	  
fundamental	  (a	  and	  c)	  and	  pulse-­‐inversion	  harmonic	  modes	  (b	  and	  d).	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Figure	  4.	  a	  (fundamental)	  and	  b	  (THI	  pulse	  inversion),	  The	  two	  sets	  of	  curves	  represent	  the	  simulated	  (full-­‐wave	  propagation)	  
spectral	  content	  from	  a	  typical	  curvilinear	  array	  [center	  frequency	  =	  3.8	  MHz	  (a),	  3.0	  MHz	  (b)]	  at	  0	  mm	  (top	  set)	  and	  then	  at	  12	  	  
(or	  8)	  cm	  of	  depth	  (bottom	  set)	  after	  propagating	  through	  an	  attenuating	  medium	  (0.5	  dB	  cm–1	  MHz–1,	  plus	  1.3	  dB	  cm–1	  MHz–1	  
at	  skin	  line).	  For	  each	  set,	  the	  green	  (blue)	  line	  is	  the	  received	  signal	  spectra	  with	  120-­‐V	  transmit,	  and	  the	  pink	  (red)	  line	  is	  the	  
received	  signal	  spectrum	  with	  60-­‐V	  transmit.	  The	  bandwidth	  difference	  between	  the	  depths	  is	  about	  0.25	  MHz	  for	  the	  
fundamental	  and	  1	  MHz	  for	  the	  harmonic	  sequence.	  c	  and	  d,	  Corresponding	  peak	  value	  of	  the	  received	  pulse	  as	  a	  function	  of	  
depth	  for	  the	  fundamental	  (c)	  and	  THI	  (d)	  cases.	  Assuming	  signals	  below	  –45	  dB	  will	  not	  be	  detected,	  these	  images	  indicate	  that	  
a	  100%	  increase	  in	  transmit	  voltage	  leads	  to	  a	  1.25-­‐cm	  (12%,	  fundamental)	  and	  2.25-­‐cm	  (25%,	  THI)	  increase	  in	  depth	  of	  
penetration.	  Data	  provided	  by	  Fujifilm	  SonoSite.	  
Increasing	  the	  transmit	  voltage	  causes	  more	  waveform	  distortion	  at	  any	  given	  depth,	  leading	  to	  more	  
harmonic	  generation.	  Figure	  4	  shows	  that	  with	  a	  6-­‐dB	  increase	  in	  transmit	  voltage,	  there	  is	  a	  6-­‐dB	  
increase	  in	  the	  fundamental	  and	  a	  12-­‐dB	  increase	  in	  THI	  signal	  at	  all	  depths.	  In	  addition,	  assuming	  –45	  
dB	  as	  the	  minimum	  detection	  level,	  the	  corresponding	  increases	  in	  depth	  of	  penetration	  are	  12%	  
(fundamental)	  and	  25%	  (THI),	  with	  the	  increased	  depth	  of	  penetration	  for	  THI	  approaching	  that	  obtained	  
with	  the	  lower	  transmit	  voltage	  in	  the	  fundamental	  mode.	  It	  was	  previously	  concluded	  that	  for	  B-­‐mode	  
imaging,	  a	  6-­‐dB	  increase	  in	  transmit	  voltage	  would	  not	  produce	  a	  dramatic	  improvement	  in	  either	  
penetration	  or	  image	  quality.116	  In	  contrast,	  for	  THI,	  a	  6-­‐dB	  increase	  in	  the	  transmit	  voltage	  may	  
generate	  a	  detectable	  improvement	  in	  depth	  of	  penetration	  and	  image	  quality.	  It	  should	  be	  noted	  that	  
these	  analyses	  did	  not	  consider	  phase	  aberration	  issues,	  which	  are	  more	  detrimental	  for	  fundamental	  
imaging	  than	  THI;	  thus,	  it	  may	  be	  that	  increased	  transmit	  voltage	  will	  have	  additional	  benefit	  for	  THI.	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This	  finding	  supports	  the	  hypothesis	  that	  increased	  acoustic	  output	  in	  the	  context	  of	  harmonic	  imaging	  
could	  have	  significant	  clinical	  benefit.	  However,	  controlled	  studies	  are	  needed	  to	  determine	  the	  
magnitude	  of	  the	  improvement.	  
6.2 Acoustic	  Radiation	  Force–Based	  Imaging	  
Recently,	  ARFI-­‐based	  elasticity	  imaging	  methods	  developed	  in	  research	  laboratories	  have	  become	  
commercially	  available.	  These	  tools	  employ	  focused	  “pushing	  pulses”	  that	  generate	  acoustic	  radiation	  
force	  in	  the	  tissue	  and	  monitor	  the	  resulting	  tissue	  dynamic	  displacement	  response	  with	  conventional	  
ultrasonic	  motion-­‐tracking	  methods.	  The	  tissue	  displacement	  magnitude	  is	  on	  the	  order	  of	  microns.	  
Both	  the	  displacement	  magnitude	  and	  the	  speed	  of	  the	  shear	  wave	  propagation	  away	  from	  the	  pushing	  
location	  are	  related	  to	  the	  viscoelastic	  tissue	  properties;	  thus,	  these	  modalities	  provide	  an	  additional	  
contrast	  mechanism	  that	  is	  adjunctive	  to	  the	  information	  provided	  by	  B-­‐mode	  imaging.8	  Initial	  studies	  
from	  early	  adopters	  have	  reported	  promising	  findings	  for	  a	  wide	  variety	  of	  clinical	  applications,	  
including,	  for	  example,	  noninvasively	  staging	  liver	  fibrosis	  (Virtual	  Touch	  [Siemens],117	  SWE	  [SuperSonic	  
Imagine,118	  ElastPQ	  [Philips]),	  and	  breast	  lesion	  characterization	  (SWE,119	  Virtual	  Touch120).	  
However,	  these	  tools	  have	  been	  developed	  within	  the	  current	  guidelines	  for	  MI	  and	  TI,	  and	  limitations	  
are	  being	  identified	  that	  might	  be	  alleviated	  with	  the	  use	  of	  CIP.	  Studies	  routinely	  report	  depth	  
penetration	  limitations	  and	  exclude	  patients	  with	  hepatic	  lesions	  deeper	  than	  6–8	  cm121;	  technical	  
failure	  and	  unreliable	  measurement	  rates	  for	  liver	  stiffness	  have	  been	  reported	  to	  increase	  both	  with	  an	  
elevated	  patient	  body	  mass	  index	  (BMI,	  a	  measure	  of	  obesity)122,123	  and	  in	  the	  presence	  of	  significant	  
hepatic	  fibrosis.118,122	  Further,	  most	  protocols	  report	  median	  values	  from	  10–12	  successful	  replicate	  
measurements,124	  leading	  to	  increased	  time	  and	  repeated	  measurements	  when	  technical	  failures	  occur.	  
While	  studies	  are	  required	  to	  determine	  the	  causes	  of	  the	  failures	  in	  these	  different	  scenarios,	  a	  leading	  
hypothesis	  is	  that	  limited	  tissue	  displacement	  magnitude	  is	  a	  major	  contributing	  factor,	  which	  might	  be	  
alleviated	  with	  CIP.	  Preliminary	  results	  from	  an	  ongoing	  study	  exploring	  this	  issue	  suggest	  that	  the	  
number	  of	  technically	  successful	  measurements	  increases,	  and	  the	  displacement	  estimation	  jitter	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Figure	  5.	  Left,	  Percentage	  of	  successful	  shear	  wave	  speed	  measurements	  (8	  attempts/patient/energy	  level)	  as	  a	  function	  of	  
transmit	  energy	  level	  (E	  =	  transmit	  voltage2/element	  impedance)	  from	  22	  patients	  with	  a	  range	  of	  liver	  fibrosis	  stages	  and	  BMIs	  
(E	  =	  4	  mJ	  is	  typical	  for	  current	  commercial	  systems).	  Right,	  Shear	  wave	  displacement	  estimation	  noise	  level	  (jitter)	  in	  these	  
sequences	  obtained	  using	  harmonic	  imaging	  as	  a	  function	  of	  MI	  level.	  Note	  the	  increased	  yield	  and	  decreased	  jitter	  levels	  
associated	  with	  CIP	  in	  these	  data.	  Data	  provided	  from	  an	  ongoing	  IRB-­‐approved	  study	  at	  Duke	  University.125	  	  
While	  noninvasive	  liver	  stiffness	  measurement	  systems	  are	  available	  that	  do	  not	  employ	  acoustic	  
radiation	  force,	  these	  systems	  are	  also	  challenged	  by	  the	  obese	  population.	  The	  FibroScan	  system,	  which	  
noninvasively	  measures	  liver	  stiffness	  using	  1-­‐dimensional	  ultrasound	  and	  an	  external	  vibration	  source,	  
suffers	  from	  measurement	  failure	  and	  unreliable	  estimates	  in	  obese	  subjects.126	  Another	  alternative	  is	  
magnetic	  resonance	  elastography	  (MRE).127	  However,	  MRE	  generally	  requires	  a	  separate	  clinic	  visit	  and	  
considerable	  cost	  as	  compared	  to	  ultrasonically	  based	  shear	  wave	  methods,	  and	  it	  is	  not	  uncommon	  for	  
morbidly	  obese	  patients	  to	  be	  excluded	  from	  MRE	  when	  they	  cannot	  fit	  inside	  the	  imaging	  apparatus.	  
The	  development	  of	  ARFI-­‐based	  methods	  that	  successfully	  characterize	  hepatic	  disease	  in	  the	  obese	  
patient	  population	  thus	  remains	  a	  worthy	  goal,	  which	  these	  initial	  data	  suggest	  would	  be	  fostered	  by	  the	  
use	  of	  CIP.	  
7 Discussion	  
The	  scientific	  rationale	  for	  the	  assumptions	  employed	  during	  the	  development	  of	  the	  MI	  is	  discussed	  in	  
section	  2.2.	  It	  is	  shown	  that	  if	  more	  accurate	  assumptions	  were	  employed,	  the	  following	  changes	  would	  
be	  appropriate.	  First,	  in	  most	  soft	  tissues,	  any	  bubble	  that	  is	  present	  will	  likely	  be	  surrounded	  by	  
viscoelastic	  material	  rather	  than	  water,	  and	  in	  this	  case,	  the	  threshold	  for	  inertial	  cavitation	  increases	  by	  
a	  factor	  of	  2	  or	  more	  at	  all	  frequencies.	  Second,	  in	  contrast	  to	  the	  assumed	  single-­‐cycle	  pulse	  duration,	  
pulses	  of	  several	  hundred	  acoustic	  periods	  are	  typically	  employed	  by	  ARFI	  methods,	  and	  in	  soft	  tissues,	  
although	  longer	  pulse	  durations	  are	  associated	  with	  decreased	  thresholds	  for	  inertial	  cavitation,	  they	  
remain	  within	  95%	  of	  those	  at	  one	  period.	  Taken	  together,	  these	  findings	  suggest	  that	  ignoring	  the	  
effects	  of	  pulse	  duration	  remains	  reasonable	  under	  the	  assumption	  of	  the	  presence	  of	  a	  preexisting	  
bubble,	  while	  the	  predicted	  threshold	  (if	  determined	  by	  safety,	  rather	  than	  preexisting	  levels	  from	  1976)	  
might	  be	  doubled.	  Third,	  the	  frequency	  dependence	  of	  the	  threshold	  for	  inertial	  cavitation	  in	  
viscoelastic	  materials	  is	  theoretically	  shown	  to	  be	  better	  modeled	  by	  a	  power	  of	  0.75,	  and	  experimental	  
evidence	  of	  cavitation-­‐based	  capillary	  damage	  in	  the	  presence	  of	  contrast	  agents	  suggests	  that	  a	  power	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of	  1.0,	  rather	  than	  0.5,	  more	  accurately	  predicts	  a	  threshold	  for	  this	  bioeffect.	  Thus,	  changing	  the	  
frequency	  dependence	  in	  Equation	  1	  could	  be	  justified.	  
However,	  while	  modifying	  Equation	  1	  per	  the	  above	  findings	  (specifically	  increasing	  the	  power	  of	  the	  
frequency	  dependence	  and	  development	  of	  a	  more	  accurate	  derating	  scheme)	  could	  potentially	  provide	  
more	  accurate	  predictions	  of	  in	  situ	  parameters,	  the	  FDA	  guidelines	  are	  based	  on	  calculating	  a	  threshold	  
within	  preexisting	  maximum	  recommended	  levels.	  Any	  modifications	  to	  the	  governing	  equation	  would	  
necessarily	  involve	  recalculating	  the	  preexisting	  levels	  as	  well.	  	  	  
One	  strength	  of	  the	  MI,	  as	  currently	  implemented,	  is	  that	  it	  provides	  a	  valuable	  design	  parameter	  to	  
which	  existing	  ultrasound	  systems	  have	  been	  optimized.	  However,	  there	  is	  a	  large	  safety	  margin	  
between	  the	  guidelines	  based	  on	  preexisting	  levels	  determined	  using	  the	  MI	  formulation	  and	  the	  
threshold	  values	  that	  are	  reported	  in	  the	  literature	  for	  cavitation-­‐mediated	  bioeffects	  in	  tissues	  not	  
known	  to	  contain	  gas	  bodies.	  From	  an	  absolute	  safety	  standpoint,	  the	  literature	  summarized	  in	  section	  4	  
clearly	  supports	  the	  use	  of	  CIP	  in	  these	  tissues,	  within	  the	  limits	  of	  Table	  1.	  This	  raises	  the	  question:	  Why	  
is	  the	  disparity	  between	  absolute	  safety	  thresholds	  and	  the	  regulatory	  guidelines	  so	  large?	  First,	  the	  
regulatory	  reference	  to	  preexisting	  levels	  is	  based	  on	  the	  absence	  of	  reported	  bioeffects	  prior	  to	  1976,	  
rather	  than	  observation	  of	  bioeffects	  at	  these	  preexisting	  levels.	  Second,	  Equation	  1	  presupposes	  the	  
existence	  of	  cavitation	  nuclei;	  in	  tissues	  not	  known	  to	  contain	  gas	  bodies,	  this	  model	  appears	  to	  be	  
invalid.	  	  It	  is	  noteworthy	  that	  the	  likelihood	  of	  detection	  of	  spontaneously	  nucleated	  bubbles	  increases	  
with	  increasing	  numbers	  of	  acoustic	  periods	  at	  acoustic	  pressures	  near	  threshold	  values	  for	  a	  given	  
tissue.	  The	  apparent	  disparity	  between	  the	  findings	  that	  pulse	  duration	  has	  a	  negligible	  effect	  on	  
cavitation	  thresholds	  in	  soft	  tissues	  (Figure	  1B)	  and	  the	  empirically	  reported	  dependence	  of	  cavitation	  in	  
soft	  tissues	  on	  pulse	  duration	  (Table	  1)	  likely	  arises	  from	  the	  fact	  that	  pr-­‐existing	  cavitation	  nuclei	  of	  
optimal	  diameter	  were	  not	  present	  in	  the	  experiments.	  Thus,	  we	  conclude	  that	  the	  observed	  thresholds	  
in	  Table	  1	  must	  be	  related	  to	  either	  the	  presence	  of	  very	  small	  bubbles	  (R	  ≈	  10	  nm)	  or	  the	  pressures	  
required	  for	  spontaneous	  nucleation	  of	  bubbles,	  rather	  than	  cavitation	  of	  preexisting	  bubbles	  of	  optimal	  
size.	  
Given	  the	  large	  safety	  margin	  provided	  by	  the	  current	  guidance,	  it	  seems	  reasonable	  to	  suggest	  that	  
increasing	  the	  maximum	  recommended	  level	  given	  in	  the	  guidance	  would	  be	  warranted	  if	  a	  significant	  
increase	  in	  diagnostic	  information	  could	  be	  obtained	  thereby.	  This	  might	  also	  be	  warranted	  if	  the	  
recommended	  level	  could	  be	  related	  to	  the	  MIE,	  rather	  than	  the	  MI.	  However,	  only	  limited	  data	  are	  
available	  to	  evaluate	  the	  potential	  clinical	  benefit,	  in	  large	  part	  because	  commercial	  systems	  are	  
designed	  to	  the	  existing	  guidelines	  and	  thus	  do	  not	  enable	  such	  studies.	  In	  the	  context	  of	  harmonic	  
imaging,	  while	  the	  predicted	  25%	  improvement	  in	  depth	  penetration	  for	  this	  imaging	  mode	  (Figure	  4)	  
combined	  with	  additional	  possible	  improvements	  due	  to	  the	  benefits	  of	  harmonic	  imaging	  in	  
overcoming	  phase	  aberration	  artifacts128	  could	  be	  significant,	  clinical	  studies	  are	  required	  to	  determine	  
the	  impact	  of	  this	  improvement.	  	  In	  the	  context	  of	  ARFI/shear	  wave	  imaging,	  as	  shown	  in	  Figure	  5,	  the	  
use	  of	  CIP	  would	  lead	  to	  improved	  measurement	  success	  in	  difficult-­‐to-­‐image	  patients.125	  However,	  
further	  studies	  are	  required	  to	  quantify	  the	  magnitude	  of	  the	  potential	  benefit.	  To	  facilitate	  this	  analysis,	  
manufacturers	  would	  need	  to	  produce	  machines	  that	  would	  allow	  the	  needed	  clinical	  data	  to	  be	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gathered	  under	  investigational	  device	  exemption	  (IDE)	  with	  IRB	  approval,	  and	  studies	  would	  need	  to	  be	  
designed	  implementing	  ALARA	  on	  an	  application-­‐specific	  basis,	  including	  risk	  analyses	  in	  the	  unlikely	  
event	  that	  cavitation	  might	  occur.	  
There	  is	  precedence	  for	  using	  elevated	  output	  levels	  in	  “difficult-­‐to-­‐image”	  scenarios	  in	  the	  diagnostic	  
imaging	  community.	  A	  multitiered	  scheme	  regarding	  safety	  levels	  has	  been	  employed	  for	  magnetic	  
resonance	  imaging	  as	  described	  in	  IEC	  60601-­‐2-­‐33	  and	  summarized	  below.	  The	  3-­‐tiered	  scheme	  is	  based	  
on	  a	  specific	  absorption	  rate	  (SAR),	  which	  is	  related	  to	  radiofrequency	  power	  absorbed	  per	  unit	  of	  mass	  
(W/kg):	  
	  
Operating	  Mode	   	   Whole-­‐Body	  SAR,	   Partial-­‐Body	  SAR,	   Head	  SAR,	  
	   	   	   	   W/kg	   	   	   W/kg	   	   	   W/kg	  
Normal	  	   	   	   2	   	   	   2–10	   	   	   3.2	  
First-­‐level	  controlled	   	   4	   	   	   4–10	   	   	   3.2	  
Second-­‐level	  controlled	  	   >4	   	   	   >(4–10)	  	   	   >3.2	  
	  
The	  partial-­‐body	  SAR	  limits	  scale	  dynamically	  with	  the	  ratio	  “exposed	  patient	  mass/patient	  mass.”	  	  In	  
the	  first-­‐level	  controlled	  mode,	  medical	  supervision	  is	  required.	  In	  the	  second-­‐level	  controlled	  mode,	  
explicit	  ethical	  approval	  from	  the	  IRB	  is	  required.129	  Note	  that	  the	  first	  2	  modes	  are	  presumably	  widely	  
employed	  as	  needed,	  without	  specific	  IRB	  approval.	  
	  
In	  the	  context	  of	  ultrasonic	  imaging,	  if	  clinical	  benefit	  is	  demonstrated	  using	  CIP	  for	  specific	  clinical	  
applications	  under	  IDE	  with	  IRB	  approval,	  a	  similar	  3-­‐tier	  approach	  might	  be	  pursued.	  The	  normal	  
operating	  mode	  would	  include	  any	  output	  up	  to	  the	  current	  guideline,	  MI	  =	  1.9.	  In	  the	  first-­‐level	  
controlled	  tier,	  the	  MIE	  would	  be	  estimated	  in	  addition	  to	  the	  MI,	  and	  the	  MIE	  would	  remain	  below	  the	  
MIE	  threshold	  values	  for	  cavitation	  reported	  in	  Table	  1.	  This	  tier	  would	  require	  imaging	  be	  performed	  
under	  medical	  supervision	  by	  a	  qualified	  practitioner.	  One	  possible	  implementation	  approach	  would	  be	  
that	  CIP	  could	  be	  initiated	  by	  a	  button	  or	  foot	  pedal	  on	  the	  user	  interface.	  The	  CIP	  mode	  would	  be	  active	  
only	  with	  positive	  action	  by	  the	  operator	  and	  restricted	  to	  some	  predetermined	  time	  limit,	  which	  would	  
be	  related	  to	  the	  time	  required	  to	  obtain	  the	  required	  diagnostic	  information	  as	  dictated	  by	  the	  
suggested	  IRB/IDE-­‐governed	  studies.	  The	  CIP	  images	  would	  be	  stored	  for	  immediate	  or	  later	  
analysis.	  The	  CIP	  mode	  acoustic	  output	  level	  could	  be	  varied,	  or	  could	  be	  fixed,	  but	  it	  could	  not	  exceed	  a	  
value	  based	  on	  an	  MIE	  safety	  analysis.	  The	  need	  for	  and	  use	  of	  a	  real-­‐time	  display	  of	  the	  MIE	  would	  
need	  to	  be	  discussed.	  
	  
If	  clinical	  benefit	  were	  demonstrated	  under	  tier	  2,	  a	  third	  tier	  could	  be	  introduced,	  which	  would	  permit	  
the	  thresholds	  in	  Table	  1	  to	  be	  approached	  but	  would	  also	  require	  imaging	  be	  performed	  under	  medical	  
supervision	  by	  a	  qualified	  practitioner	  and	  IRB	  oversight.	  A	  method	  for	  identifying	  the	  boundary	  
between	  levels	  2	  and	  3,	  however,	  is	  not	  obvious.	  	  Manufacturers	  typically	  employ	  a	  self-­‐imposed	  margin	  
of	  15%–30%	  below	  FDA-­‐recommended	  guidelines	  when	  establishing	  the	  output	  for	  diagnostic	  scanners	  
(thus,	  most	  systems	  do	  not	  currently	  employ	  outputs	  exceeding	  MI	  =	  1.6).	  This	  allows	  for	  probe	  
variability,	  system	  variability,	  and	  measurement	  uncertainty.	  Choosing	  a	  lower	  target	  value	  might	  also	  
be	  done	  by	  a	  manufacturer	  to	  facilitate	  lower	  sample	  rates	  for	  acoustic	  testing.	  If	  we	  arbitrarily	  select	  a	  
safety	  margin	  of	  20%	  with	  respect	  to	  the	  minimum	  MIE	  in	  Table	  1	  for	  the	  MHz	  range	  (5.0),	  this	  leads	  to	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an	  MIE	  of	  4	  for	  the	  threshold	  between	  the	  two	  investigational	  output	  levels.	  In	  addition,	  one	  could	  
consider	  including	  pulse	  duration	  or	  duty	  cycle	  dependencies	  for	  the	  third	  tier.	  For	  all	  of	  the	  proposed	  
tiers	  shown	  in	  the	  table	  below,	  an	  additional	  constraint	  would	  be	  that	  the	  TI	  values	  would	  need	  to	  be	  
within	  current	  guidelines.	  
Operating	  mode	   	   MI	   	   	   	   	   	   	  
Normal	  	   	   	   MI	  ≤1.9	  	   	   	  
First-­‐level	  controlled	   	   MIE	  ≤4	   	   	   	  
Second-­‐Level	  controlled	  	   MIE	  >4	   	  
It	  is	  important	  to	  note	  that	  while	  these	  recommendations	  are	  based	  on	  all	  of	  the	  evidence	  available,	  the	  
extent	  of	  that	  evidence	  is	  rather	  limited.	  There	  is	  a	  need	  for	  information	  on	  several	  parameters	  affecting	  
cavitation	  thresholds	  in	  tissue.	  First	  and	  foremost	  among	  these	  is	  the	  value	  of	  the	  threshold	  itself	  in	  each	  
of	  several	  frequently	  scanned	  tissues	  not	  known	  to	  contain	  gas	  bodies.	  These	  include	  heart,	  liver,	  
kidney,	  and	  brain.	  Most	  of	  the	  information	  currently	  available	  has	  been	  obtained	  in	  the	  range	  of	  0.66–
1.72	  MHz	  (see	  Table	  1),	  so	  extending	  this	  range	  to	  higher	  frequencies	  is	  paramount.	  Second,	  the	  pulse	  
durations	  shown	  in	  Table	  1	  vary	  widely,	  and	  there	  is	  an	  obvious	  need	  for	  more	  uniformity	  among	  the	  
results.	  Third,	  there	  is	  also	  significant	  variation	  in	  the	  pulse	  repetition	  frequency	  and	  the	  total	  number	  of	  
pulses	  among	  the	  exposures	  used	  in	  the	  studies	  compiled	  for	  Table	  1.	  Greater	  consistency	  in	  the	  
exposure	  conditions	  used	  by	  various	  laboratories	  would	  allow	  more	  thoughtful	  extrapolation	  to	  other	  
conditions	  that	  have	  yet	  to	  be	  investigated	  or	  that	  cannot	  be	  studied	  at	  all.	  	  Fourth,	  there	  is	  also	  a	  need	  
to	  standardize	  the	  definition	  of	  threshold	  and	  the	  technique	  used	  in	  its	  determination.	  The	  range	  of	  the	  
technical	  details	  to	  be	  addressed	  in	  even	  the	  simplest	  approach	  can	  be	  so	  broad	  that	  ensuring	  
comparability	  across	  laboratories	  can	  become	  a	  daunting	  task.	  Finally,	  whatever	  technique	  is	  adopted,	  it	  
must	  be	  sufficiently	  simple	  as	  to	  allow	  the	  greatest	  number	  of	  researchers	  to	  participate	  in	  the	  
acquisition	  of	  the	  desired	  data.	  With	  this	  information	  in	  hand,	  the	  creation	  of	  a	  rigorous,	  science-­‐based	  
safety	  index	  for	  cavitation-­‐induced	  adverse	  biological	  effects	  would	  be	  possible.	  
Based	  on	  established	  guidelines	  and	  historical	  experience,	  there	  is	  a	  widely	  held	  perception	  that	  
diagnostic	  ultrasound	  is	  safe.	  Although	  implementation	  of	  the	  ALARA	  principle	  is	  recommended	  for	  all	  
ultrasonic	  imaging	  examinations,	  the	  presumed	  safety	  of	  the	  modality	  can	  lead	  to	  laxity	  among	  the	  
clinical	  community	  in	  consideration	  of	  risk.	  If	  methods	  are	  introduced	  enabling	  CIP	  for	  specific	  
applications,	  it	  would	  be	  possible	  that	  the	  uninformed	  user	  might	  employ	  CIP	  in	  an	  inappropriate	  setting	  
(eg,	  in	  the	  presence	  of	  contrast	  agents).	  As	  with	  all	  diagnostic	  imaging	  scenarios,	  this	  risk	  would	  need	  to	  
be	  balanced	  against	  the	  potential	  benefit	  of	  providing	  access	  to	  	  the	  imaging	  studies	  using	  CIP	  for	  their	  
intended	  purpose	  (ie,	  to	  obtain	  diagnostic	  information	  that	  could	  not	  otherwise	  be	  obtained	  in	  difficult-­‐
to-­‐image	  patients).	  
Taking	  into	  consideration	  the	  paucity	  of	  data	  on	  which	  these	  recommendations	  are	  based,	  it	  is	  deemed	  
prudent	  to	  exclude	  certain	  classes	  of	  patients	  and	  certain	  structures	  in	  potential	  patients	  during	  the	  
period	  of	  exploratory	  investigations.	  While	  this	  may	  deny	  potentially	  beneficial	  medical	  imaging	  to	  
some,	  this	  represents	  a	  straightforward	  application	  of	  the	  age-­‐old	  dictum,	  “First,	  do	  no	  harm.”	  	  Among	  
the	  obvious	  classes	  of	  patients	  to	  avoid	  are	  embryos,	  fetuses,	  and	  neonates	  and	  also	  any	  subject	  who	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has	  been	  given	  a	  microbubble	  contrast	  agent	  within	  the	  preceding	  24	  hours.	  Structures	  that	  are	  
potentially	  sensitive	  to	  CIP	  are	  lung,	  intestine,	  and	  any	  other	  tissue	  suspected	  of	  harboring	  undissolved	  
gas,	  eg,	  tissues	  having	  active	  infections.	  Additionally,	  because	  no	  data	  are	  available	  with	  respect	  to	  
ophthalmic	  imaging	  with	  MI	  values	  above	  0.23,	  further	  studies	  would	  be	  required	  to	  assess	  the	  potential	  
sensitivity	  of	  the	  eye.	  The	  precise	  manner	  by	  which	  to	  avoid	  scanning	  such	  tissues	  is	  best	  left	  to	  the	  
skilled	  user,	  but	  there	  is	  a	  significant	  need	  for	  education	  and	  understanding	  of	  the	  safety	  issues	  involved	  
with	  CIP	  before	  its	  use	  can	  be	  contemplated.	  Although	  the	  guidelines	  recommended	  above	  are	  
considered	  to	  encompass	  a	  robust	  safety	  margin,	  this	  is	  an	  investigational	  procedure	  that	  may	  involve	  a	  
level	  of	  risk	  that	  is	  greater	  than	  is	  usually	  the	  case	  for	  diagnostic	  ultrasound.	  Therefore,	  there	  is	  a	  very	  
real	  need	  for	  assessing	  the	  risk-­‐to-­‐benefit	  ratio	  on	  a	  clinical	  application-­‐specific	  basis,	  assessing	  the	  MIE	  
as	  well	  as	  the	  MI,	  and	  for	  taking	  the	  application	  of	  the	  ALARA	  principle	  seriously.	  
Given	  the	  lack	  of	  an	  accepted	  standard	  for	  determination	  of	  MIE	  and	  the	  existing	  challenges	  for	  the	  
various	  investigational	  methods,	  at	  this	  time,	  it	  seems	  prudent	  to	  recommend	  that	  studies	  should	  be	  
designed	  to	  report	  both	  the	  MI	  and	  an	  estimate	  of	  MIE.	  Ideally	  the	  MIE	  would	  be	  estimated	  consistently	  
between	  reports.	  
The	  safety	  of	  CIP	  exposures	  may	  be	  assessed	  in	  terms	  of	  2	  primary	  mechanisms,	  mechanical	  and	  
thermal.	  Mechanical	  effects	  can	  be	  divided	  further	  into	  cavitational	  and	  noncavitational	  (eg,	  radiation	  
force,	  radiation	  torque,	  and	  acoustic	  streaming).	  Some	  studies	  have	  posited	  that	  noncavitational	  effects	  
are	  a	  source	  of	  stimulation	  in	  tissues	  with	  apparently	  elevated	  sensitivity	  (ie,	  brain	  and	  cardiac	  tissue),	  
although	  these	  effects	  are	  generally	  reversible.	  A	  device's	  ability	  to	  induce	  damage	  by	  a	  cavitation	  
mechanism	  is	  determined	  almost	  entirely	  by	  the	  frequency	  and	  maximum	  rarefactional	  pressure	  
amplitude	  in	  vivo.	  This	  is	  because	  cavitation	  is	  a	  threshold	  phenomenon,	  and	  if	  the	  output	  level	  of	  any	  
device	  never	  exceeds	  the	  threshold,	  then	  the	  risk	  from	  exposure	  at	  any	  level	  below	  the	  threshold	  is	  
negligible.	  With	  regard	  to	  thermal	  mechanisms,	  safety	  can	  be	  assessed	  as	  is	  done	  currently	  for	  any	  other	  
imaging	  mode,	  ie,	  by	  use	  of	  the	  maximum	  time-­‐average	  intensity	  and	  the	  TI,	  where	  the	  FDA	  guidance	  
requires	  that	  an	  explanation	  be	  provided	  for	  a	  TI	  value	  greater	  than	  6.0.5	  If	  deemed	  necessary	  for	  
particular	  exposure	  conditions	  for	  elastography,	  these	  metrics	  may	  be	  augmented	  with	  an	  analysis	  of	  
the	  transient	  temperature	  rise	  associated	  with	  ARFI	  bursts,	  which	  would	  be	  particularly	  important	  
where	  bone	  and	  air	  interfaces	  are	  involved,	  as	  reported	  by	  Liu	  et	  al.130	  	  
8 Summary/Consensus	  Statements	  	  
In	  this	  article,	  we	  summarized	  the	  current	  formulation	  of	  the	  MI	  and	  presented	  evidence	  supporting	  
modifications	  of	  some	  assumptions	  under	  the	  current	  formulation.	  Further,	  we	  summarized	  the	  existing	  
experimental	  evidence	  for	  cavitation	  thresholds	  in	  the	  literature	  in	  nonfetal	  tissues	  not	  known	  to	  
contain	  preexisting	  gas	  bodies.	  We	  discussed	  the	  need	  for	  and	  challenges	  associated	  with	  accurate	  
estimation	  of	  in	  situ	  exposures	  and	  the	  use	  of	  the	  MIE	  as	  a	  metric	  to	  quantify	  such	  estimates.	  In	  
addition,	  we	  discussed	  2	  imaging	  methods	  that	  might	  benefit	  from	  CIP	  and	  the	  lack	  of	  data	  available	  to	  
enable	  evaluation	  of	  potential	  clinical	  benefits.	  Through	  this	  analysis,	  we	  conclude	  the	  following:	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1) From	  a	  mechanistic	  point	  of	  view,	  the	  probability	  that	  exposure	  to	  diagnostic	  ultrasound	  
(emitted	  by	  devices	  cleared	  under	  current	  track	  3	  guidelines)	  will	  induce	  cavitation	  in	  tissue	  not	  
known	  to	  contain	  gas	  bodies	  is	  essentially	  zero,	  except	  in	  very	  unusual	  cases	  of	  long	  fluid	  paths	  
or	  specific	  inhomogeneous	  media	  as	  discussed	  in	  section	  3.	  
2) Given	  the	  generally	  large	  safety	  margin	  provided	  by	  the	  current	  guidance	  for	  tissues	  not	  known	  
to	  contain	  gas	  bodies,	  it	  seems	  reasonable	  to	  suggest	  that	  exceeding	  the	  maximum	  MI	  level	  
given	  in	  the	  guidance5	  could	  be	  warranted	  without	  concern	  for	  increased	  risk	  of	  cavitation	  in	  
these	  tissues,	  if	  pr.3	  is	  approximately	  equal	  to	  the	  actual	  value	  of	  pr	  in	  situ,	  ie,	  when	  the	  MI	  is	  
approximately	  equal	  to	  the	  MIE.	  	  	  	  
3) At	  this	  time,	  there	  is	  a	  paucity	  of	  data/studies	  investigating	  the	  potential	  increase	  in	  diagnostic	  
information	  that	  might	  be	  afforded	  by	  the	  use	  of	  CIP.	  
4) Professional	  societies,	  manufacturers,	  academics,	  and	  other	  interested	  parties	  should	  cooperate	  
and	  work	  to	  enable	  studies	  of	  investigational	  use	  of	  CIP	  when	  there	  is	  reasonable	  expectation	  of	  
substantial	  clinical	  benefit.	  
5) Studies	  investigating	  CIP	  should	  report	  both	  the	  MI	  and	  an	  estimate	  of	  the	  MIE.	  
6) A	  standard	  method	  for	  MIE	  estimation	  is	  needed	  that	  accounts	  for	  acoustic	  nonlinearity	  and	  
attenuation.	  
7) The	  maximum	  MIE	  for	  investigational	  CIP	  studies	  should	  be	  determined	  by	  a	  risk-­‐benefit	  analysis	  
on	  an	  application-­‐specific	  basis.	  
8) In	  keeping	  with	  the	  recommendations	  of	  IEC	  60601-­‐2-­‐37	  regarding	  risk-­‐benefit	  analyses,	  and	  the	  
current	  knowledge	  pertaining	  to	  nonfetal	  tissues	  in	  the	  absence	  of	  known	  gas	  bodies	  (eg,	  Table	  
1),	  we	  recommend	  investigation	  of	  MIE	  levels	  up	  to	  4.0	  for	  initial	  studies	  evaluating	  CIP	  in	  these	  
tissues	  when	  there	  is	  reasonable	  expectation	  of	  substantial	  clinical	  benefit.	  
9) Based	  	  on:	  (1)	  increased	  risk	  of	  cavitation,	  (2)	  increased	  potential	  sensitivity	  to	  CIP,	  (3)	  risk	  of	  
harm	  if	  cavitation	  were	  to	  occur,	  or	  (4)	  lack	  of	  sufficient	  data	  to	  assess	  risk,	  the	  following	  specific	  
human	  tissues	  require	  further	  study	  and	  justification	  before	  applying	  the	  above	  
recommendations	  on	  CIP	  for	  diagnostic	  imaging:	  
i) Tissues	  known	  to	  contain	  gas	  bodies	  (eg,	  lung,	  intestine,	  and	  regions	  with	  infection);	  
ii) Tissues	  that	  contain	  ultrasound	  contrast	  agents;	  
iii) Fetal	  tissues;	  
iv) Ophthalmic	  tissues;	  and	  
v) Tissues	  known	  to	  be	  sensitive	  to	  ultrasonic	  stimulation,	  such	  as	  the	  CNS	  and	  cardiac	  tissues.	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Appendix	  A:	  Summary	  of	  IEC	  TS	  61949	  
Uncertainties	  in	  the	  estimation	  and	  control	  of	  in	  situ	  ultrasonic	  output	  values	  are	  exacerbated	  as	  output	  
pressures	  increase	  due	  to	  effects	  associated	  with	  nonlinear	  acoustic	  propagation	  in	  water,	  the	  standard	  
medium	  used	  for	  diagnostic	  medical	  ultrasound	  acoustic	  output	  measurements	  due	  to	  its	  ready	  
availability	  and	  maintainability,	  and	  the	  repeatability	  of	  measurements	  made	  using	  it	  (IEC	  62359,	  IEC	  
62127,	  and	  AIUM/NEMA	  measurement	  standards).	  
These	  nonlinear	  effects	  include	  harmonic	  generation,	  with	  subsequent	  increased	  frequency-­‐dependent	  
absorption,	  and	  waveform	  saturation	  and	  distortion,	  with	  accompanying	  asymmetry	  of	  the	  compression	  
and	  rarefaction	  pressure	  half-­‐cycles.24	  
These	  effects	  also	  occur	  in	  tissue	  and	  are	  made	  use	  of	  in	  ultrasound	  systems’	  tissue	  harmonic	  modes.	  In	  
fact,	  the	  nonlinearity	  parameter,	  β,	  for	  many	  tissues	  is	  higher	  than	  β	  	  for	  water	  (=	  5.2).	  However,	  the	  
overall	  effects	  are	  less	  severe	  in	  tissue	  than	  in	  water,	  being	  more	  quickly	  balanced	  by	  the	  increased	  
attenuation	  in	  tissues.	  A	  measure	  of	  this	  balance	  is	  the	  Goldberg	  number	  (a	  nondimensional	  number	  
proportional	  to	  the	  ratio	  of	  the	  nonlinearity	  parameter	  to	  the	  attenuation	  coefficient),	  which	  has	  much	  
higher	  values	  for	  water	  than	  tissue.33	  
With	  increasing	  pressure	  amplitude	  and	  spectral	  range,	  measurement	  uncertainty	  increases	  due	  to	  
measurement	  equipment	  bandwidth	  and	  response	  uniformity	  limitations	  and	  due	  to	  migration	  toward	  
the	  transducer	  of	  the	  apparent	  positions	  of	  maximum	  pressure	  and	  intensity.	  As	  saturation	  and	  
nonlinear	  absorption	  losses	  increase,	  the	  accuracy	  of	  traditional	  fixed-­‐attenuation	  mathematical	  tissue	  
models	  declines.	  
IEC	  TS	  6194934	  	  is	  a	  technical	  specification	  providing	  a	  standard	  scheme	  for	  quantifying	  a	  threshold	  for	  
the	  onset	  of	  nonlinear	  distortion	  and	  loss.	  It	  specifies	  a	  method	  for	  scaling	  up	  measurements	  from	  the	  
“quasilinear”	  region	  in	  water	  to	  the	  nonlinear	  region	  so	  that	  tissue	  attenuation	  models	  can	  provide	  
more	  accurate	  results.	  The	  scaling	  up	  is	  accomplished	  by	  multiplying	  quasilinear	  values,	  measured	  at	  the	  





close	  to	  the	  transducer	  radiating	  surface,	  where	  effects	  of	  nonlinear	  propagation	  have	  not	  yet	  been	  
generated.	  	  
The	  local	  distortion	  parameter,	   qσ ,	  defined	  and	  used	  by	  IEC	  TS	  61949,	  is	  expressed	  as:	  	  








βπ .	  	  
The	  units	  of	  the	  constituent	  parameters	  are	  arranged	  to	  make	   qσ 	  nondimensional:	  z	  is	  distance;	  p	  is	  
acoustic	  pressure;	  fawf	  is	  acoustic	  center	  frequency;	  β	  is	  the	  nonlinearity	  parameter;	  ρ	  is	  density;	  c	  is	  the	  
acoustic	  propagation	  speed;	  and	  Fa	  is	  the	  “local	  area	  factor”:	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where	   SAeffA and , 6b dBA − are,	  respectively,	  the	  effective	  area	  of	  the	  transmitting	  aperture	  and	  the	  –6-­‐dB	  
area	  of	  the	  ultrasound	  beam	  at	  depth,	  z.	  
qσ is	  a	  simplification	  of	  the	  acoustic	  propagation	  parameter,	   mσ ,	  introduced	  by	  Bacon,131	  and	  clearly	  
shows	  nonlinear	  distortion	  increasing	  with	  depth,	  frequency,	  pressure,	  and	  β	  and	  decreasing	  with	  
density,	  sound	  speed,	  and	  focusing	  gain.	  
Measurements	  following	  a	  protocol	  such	  as	  listed	  in	  IEC	  TS	  61949	  may	  require	  additional	  time	  or	  effort	  
and	  may	  create	  overestimates	  of	  actual	  tissue	  values.	  However,	  such	  measurement	  results	  may	  be	  more	  
reproducible	  from	  lab	  to	  lab	  and	  between	  measurement	  equipment.	  Finally,	  in	  the	  present	  version	  
(2007)	  of	  61949,	  a	   qσ 	  value	  of	  0.5	  is	  designated	  the	  quasilinear	  threshold,	  above	  which	  scaled-­‐up	  values	  
are	  recommended.	  Proposed	  improvements	  to	  future	  versions	  of	  IEC	  TS	  61949	  include	  raising	  the	   qσ 	  
value	  threshold	  to	  1.0,	  to	  increase	  the	  SNR	  of	  estimates.	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Appendix	  B:	  Summary	  of	  IEC	  TS	  62556	  Appendices	  E	  and	  F	  
Hybrid	  measurement/simulation	  approaches	  rely	  on	  a	  combination	  of	  low-­‐amplitude	  hydrophone	  
measurements	  in	  the	  linear	  propagation	  regime	  in	  conjunction	  with	  linear	  or	  nonlinear	  modeling.	  The	  
hydrophone	  	  measurements,	  linear	  simulation	  models,	  and	  calibration	  methods	  are	  described	  in	  detail	  
in	  Appendices	  E	  and	  F	  in	  IEC	  TS	  62556.43	  Use	  of	  the	  same	  data	  in	  combination	  with	  nonlinear	  simulation	  
can	  be	  found	  in	  Kreider	  et	  al.42	  Details	  of	  these	  approaches	  can	  be	  summarized	  as	  follows:	  	  
1)	  Acoustic	  holography	  measurements	  in	  the	  linear	  propagation	  regime	  are	  made	  in	  water.	  For	  a	  source	  
operating	  in	  CW	  mode,	  these	  measurements	  entail	  the	  scanning	  of	  a	  calibrated	  hydrophone	  over	  a	  
planar	  region	  in	  front	  of	  the	  source	  to	  determine	  pressure	  magnitude	  and	  phase	  at	  many	  discrete	  
points.	  For	  the	  more	  general	  case	  of	  a	  source	  generating	  a	  transient	  output,	  the	  relevant	  measurement	  
at	  each	  point	  comprises	  the	  full	  pressure	  waveform	  rather	  than	  just	  magnitude	  and	  phase.	  In	  both	  CW	  
and	  transient	  regimes,	  the	  source	  must	  be	  repeatedly	  triggered	  for	  each	  measurement	  to	  produce	  the	  
same	  focal	  geometry	  for	  which	  the	  MIE	  estimate	  is	  desired.	  Holography	  measurements	  can	  then	  be	  used	  
to	  define	  a	  hologram	  of	  the	  full	  3D	  sound	  field	  (ie,	  the	  “measured	  hologram”)	  and	  can	  be	  used	  to	  
mathematically	  reconstruct	  the	  pattern	  of	  vibrations	  on	  the	  surface	  of	  the	  source	  (ie,	  the	  “source	  
hologram”).	  Backward	  projection	  methods	  for	  reconstructing	  the	  source	  hologram	  include	  the	  Rayleigh	  
integral40	  and	  the	  angular	  spectrum	  or	  Fourier	  method.41	  The	  main	  use	  of	  this	  method	  is	  to	  employ	  the	  
hologram	  for	  forward	  projection	  or	  the	  simulation	  of	  the	  forward-­‐propagating	  field	  in	  water	  or	  an	  in	  situ	  
configuration	  of	  tissues.	  
	  
2)	  The	  source	  hologram	  can	  be	  used	  as	  a	  boundary	  condition	  for	  a	  forward	  projection	  model	  that	  
accounts	  for	  nonlinear	  propagation	  and	  realistic	  tissue	  properties	  to	  calculate	  the	  acoustic	  field	  in	  situ.	  
However,	  the	  source	  hologram	  was	  determined	  based	  on	  linear	  measurements	  made	  at	  a	  single	  output	  
power	  level.	  To	  provide	  suitable	  boundary	  conditions	  for	  the	  forward	  projection	  model	  at	  the	  desired	  
output	  level,	  the	  pattern	  of	  vibrations	  represented	  by	  the	  source	  hologram	  should	  be	  scaled.	  To	  
determine	  this	  scaling	  factor,	  the	  linear	  pressure	  magnitude	  at	  a	  near-­‐source	  location	  can	  be	  measured	  
at	  both	  the	  output	  level	  used	  for	  holography	  measurements	  and	  the	  output	  level	  at	  which	  the	  MIE	  is	  
desired.	  The	  measurement	  location	  ideally	  should	  be	  near	  a	  local	  pressure	  maximum,	  while	  also	  being	  
close	  to	  the	  source	  to	  minimize	  nonlinear	  propagation	  effects.	  Pressures	  measured	  at	  this	  near-­‐source	  
location	  are	  presumed	  to	  be	  proportional	  to	  the	  actual	  pressure	  generated	  at	  the	  source's	  surface,	  thus	  
providing	  a	  suitable	  metric	  for	  scaling	  the	  linear	  source	  hologram	  from	  step	  1.	  
	  
3)	  Using	  the	  scaled	  source	  hologram	  as	  a	  boundary	  condition,	  the	  nonlinear	  acoustic	  field	  in	  an	  arbitrary	  
medium	  with	  known	  properties	  can	  be	  calculated.	  Even	  nonlinear	  modeling	  of	  the	  full	  3D	  field	  
generated	  by	  an	  array	  transducer	  is	  possible,	  though	  computationally	  challenging.128,132	  	  Several	  models	  
of	  nonlinear	  acoustic	  propagation	  have	  been	  validated	  in	  medical	  applications.41,45,133–135	  These	  are	  most	  
often	  based	  on	  the	  KZK136	  or	  Westervelt	  equations.137	  
	  
4)	  Experimental	  conditions	  of	  focusing	  in	  situ	  can	  be	  very	  different	  in	  terms	  of	  propagation	  path	  and	  
acoustic	  parameters	  of	  tissue,	  and	  full	  3D	  nonlinear	  simulations	  for	  each	  situation	  can	  be	  challenging.	  A	  
nonlinear	  derating	  method35,138,139	  can	  be	  applied	  to	  predict	  nonlinear	  HIFU	  fields	  in	  situ	  for	  planning	  
exposure	  protocols	  based	  on	  the	  results	  of	  holography	  measurements	  and	  nonlinear	  modeling	  in	  water.	  
The	  method	  relies	  on	  scaling	  the	  source	  outputs	  to	  compensate	  for	  attenuation	  in	  tissue	  and	  the	  
difference	  in	  nonlinearity	  of	  tissue	  and	  water.	  The	  method	  has	  been	  shown	  to	  provide	  accurate	  results	  
for	  strongly	  or	  moderately	  focused	  transducers.	  
	  
	  
